ASK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| O00151 | T80 | Sugiyama | PDLIM1 CLIM1 CLP36 | NMTHLEAQNRIKGCTDNLtLtVARsEHKVWsPLVtEEGKRH |
| O15530 | S394 | EPSD|PSP | PDPK1 PDK1 | GNyDNLLSQFGCMQVSSSSssHsLsASDTGLPQRSGsNIEQ |
| O15530 | S398 | EPSD|PSP | PDPK1 PDK1 | NLLSQFGCMQVSSSSssHsLsASDTGLPQRSGsNIEQYIHD |
| O43423 | T101 | Sugiyama | ANP32CP PP32R1 | EKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCEV |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O95626 | T105 | Sugiyama | ANP32D PP32R2 | EKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCEV |
| P02786 | T143 | Sugiyama | TFRC | yWDDLKRKLsEKLDstDFTGtIKLLNENsyVPREAGsQKDE |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07858 | T95 | Sugiyama | CTSB CPSB | TEDLKLPAsFDAREQWPQCPtIKEIRDQGSCGSCWAFGAVE |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P10809 | T115 | Sugiyama | HSPD1 HSP60 | AKLVQDVANNtNEEAGDGtttAtVLARSIAKEGFEKISKGA |
| P10809 | T117 | Sugiyama | HSPD1 HSP60 | LVQDVANNtNEEAGDGtttAtVLARSIAKEGFEKISKGANP |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P13489 | S178 | Sugiyama | RNH1 PRI RNH | SCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKDSP |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13667 | T449 | Sugiyama | PDIA4 ERP70 ERP72 | AATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLsE |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P30086 | Y169 | Sugiyama | PEBP1 PBP PEBP | FKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK__ |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38936 | S98 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | LPtGPRRGRDELGGGRRPGtsPALLQGTAEEDHVDLsLSCT |
| P39687 | T105 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | EKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCEV |
| P45983 | T183 | EPSD|PSP | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | CTLKILDFGLARTAGtsFMMtPyVVtRyYRAPEVILGMGYK |
| P45983 | Y185 | EPSD|PSP | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | LKILDFGLARTAGtsFMMtPyVVtRyYRAPEVILGMGYKEN |
| P45985 | T261 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MAP2K4 JNKK1 MEK4 MKK4 PRKMK4 SEK1 SERK1 SKK1 | GNIKLCDFGIsGQLVDsIAKtRDAGCRPyMAPERIDPSASR |
| P46734 | S218 | SIGNOR|EPSD|PSP | MAP2K3 MEK3 MKK3 PRKMK3 SKK2 | INKEGHVKMCDFGISGyLVDsVAKtMDAGCKPYMAPERINP |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P52564 | S207 | EPSD|PSP | MAP2K6 MEK6 MKK6 PRKMK6 SKK3 | INALGQVKMCDFGISGyLVDsVAKtIDAGCKPyMAPERINP |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60660 | T103 | Sugiyama | MYL6 | QGtyEDyVEGLRVFDKEGNGtVMGAEIRHVLVtLGEKMTEE |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q05682 | T86 | Sugiyama | CALD1 CAD CDM | VEVNAQNsVPDEEAKTTtTNtQVEGDDEAAFLERLARREER |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q15056 | T100 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | KFKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRK |
| Q15691 | S40 | EPSD|PSP | MAPRE1 | MLAWINESLQLNLTKIEQLCsGAAYCQFMDMLFPGSIALKK |
| Q15691 | T154 | EPSD|PSP | MAPRE1 | EtAVAPsLVAPALNKPKKPLtsssAAPQRPIstQRTAAAPK |
| Q15691 | T206 | EPSD|PSP | MAPRE1 | VGNGDDEAAELMQQVNVLKLtVEDLEKERDFyFGKLRNIEL |
| Q16539 | T180 | EPSD|PSP | MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A | EDCELKILDFGLARHtDDEMtGyVAtRWYRAPEIMLNWMHY |
| Q16539 | Y182 | EPSD|PSP | MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A | CELKILDFGLARHtDDEMtGyVAtRWYRAPEIMLNWMHYNQ |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6ZN16 | T662 | Sugiyama | MAP3K15 ASK3 | TLEYEYDHDANGERVVLGKGtYGIVYAGRDLSNQVRIAIKE |
| Q6ZN16 | Y690 | Sugiyama | MAP3K15 ASK3 | RDLSNQVRIAIKEIPERDSRySQPLHEEIALHKYLKHRNIV |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q8IUQ4 | T235 | PSP | SIAH1 HUMSIAH | RKQAENFAYRLELNGHRRRLtWEAtPRSIHEGIATAIMNSD |
| Q8IUQ4 | T239 | PSP | SIAH1 HUMSIAH | ENFAYRLELNGHRRRLtWEAtPRSIHEGIATAIMNSDCLVF |
| Q8IUQ4 | T70 | PSP | SIAH1 HUMSIAH | PPILQCQSGHLVCSNCRPKLtCCPtCRGPLGSIRNLAMEKV |
| Q8IUQ4 | T74 | PSP | SIAH1 HUMSIAH | QCQSGHLVCSNCRPKLtCCPtCRGPLGSIRNLAMEKVANSV |
| Q969S3 | S314 | SIGNOR|EPSD|PSP | ZNF622 ZPR9 | YLGEKVGVGKICLWCNEKGKsFYStEAVQAHMNDKSHCKLF |
| Q969S3 | T318 | SIGNOR|EPSD|PSP | ZNF622 ZPR9 | KVGVGKICLWCNEKGKsFYStEAVQAHMNDKSHCKLFTDGD |
| Q99683 | S966 | GPS6|ELM|iPTMNet|EPSD|PSP | MAP3K5 ASK1 MAPKKK5 MEKK5 | KTQPKLSALSAGsNEYLRsIsLPVPVLVEDtssssEYGsVs |
| Q99683 | T690 | Sugiyama | MAP3K5 ASK1 MAPKKK5 MEKK5 | LLEYDYEYDENGDRVVLGKGtYGIVYAGRDLSNQVRIAIKE |
| Q99683 | T779 | Sugiyama | MAP3K5 ASK1 MAPKKK5 MEKK5 | GGSLSALLRSKWGPLKDNEQtIGFYTKQILEGLKYLHDNQI |
| Q99683 | T813 | GPS6|SIGNOR|EPSD|PSP | MAP3K5 ASK1 MAPKKK5 MEKK5 | YLHDNQIVHRDIKGDNVLINtYSGVLKISDFGtSKRLAGIN |
| Q99683 | T838 | GPS6|SIGNOR|EPSD|PSP|Sugiyama | MAP3K5 ASK1 MAPKKK5 MEKK5 | LKISDFGtSKRLAGINPCTEtFTGtLQyMAPEIIDKGPRGY |
| Q99683 | T842 | GPS6|SIGNOR|EPSD|PSP|Sugiyama | MAP3K5 ASK1 MAPKKK5 MEKK5 | DFGtSKRLAGINPCTEtFTGtLQyMAPEIIDKGPRGYGKAA |
| Q99683 | Y718 | Sugiyama | MAP3K5 ASK1 MAPKKK5 MEKK5 | RDLSNQVRIAIKEIPERDSRySQPLHEEIALHKHLKHKNIV |
| Q99683 | Y845 | Sugiyama | MAP3K5 ASK1 MAPKKK5 MEKK5 | tSKRLAGINPCTEtFTGtLQyMAPEIIDKGPRGYGKAADIW |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9UER7 | S176 | SIGNOR|EPSD|PSP | DAXX BING2 DAP6 | SGNNPPTHLsLDPtNAENtAsQsPRtRGsRRQIQRLEQLLA |
| Q9UER7 | S184 | SIGNOR|EPSD|PSP | DAXX BING2 DAP6 | LsLDPtNAENtAsQsPRtRGsRRQIQRLEQLLALYVAEIRR |
| Q9Y3F4 | S179 | EPSD|PSP | STRAP MAWD UNRIP | LsADDKtVRLWDHATMtEVKsLNFNMSVSSMEYIPEGEILV |
| Q9Y3F4 | T175 | EPSD|PSP | STRAP MAWD UNRIP | DKQILsADDKtVRLWDHATMtEVKsLNFNMSVSSMEYIPEG |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.146571e-07 | 6.668 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.397403e-06 | 5.855 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.409657e-06 | 5.851 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.010535e-06 | 5.995 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.169452e-06 | 5.932 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.069556e-07 | 6.151 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.975876e-06 | 5.704 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.522875e-06 | 5.258 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.502596e-06 | 5.259 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 7.300677e-06 | 5.137 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.265559e-05 | 4.898 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.255201e-05 | 4.901 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.363074e-05 | 4.865 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.519235e-05 | 4.818 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.700302e-05 | 4.769 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.921654e-05 | 4.534 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.618873e-05 | 4.335 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.237966e-05 | 4.281 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.240686e-05 | 4.281 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 7.878855e-05 | 4.104 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.225326e-05 | 4.035 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.266738e-04 | 3.897 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.460995e-04 | 3.835 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.734246e-04 | 3.761 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.905234e-04 | 3.720 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.197036e-04 | 3.658 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.160399e-04 | 3.665 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.657059e-04 | 3.576 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.411366e-04 | 3.467 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.396255e-04 | 3.357 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 4.329127e-04 | 3.364 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.263260e-04 | 3.203 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 6.681318e-04 | 3.175 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.252534e-04 | 3.140 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 7.101119e-04 | 3.149 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.479680e-04 | 3.126 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.948231e-04 | 3.100 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.965690e-04 | 3.099 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.809532e-04 | 3.055 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 9.049150e-04 | 3.043 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 9.600219e-04 | 3.018 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 9.745242e-04 | 3.011 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.928646e-04 | 3.003 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.205757e-03 | 2.919 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.264687e-03 | 2.898 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.250112e-03 | 2.903 | 1 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.378931e-03 | 2.860 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.419101e-03 | 2.848 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.347753e-03 | 2.870 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.419101e-03 | 2.848 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.529477e-03 | 2.815 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.811437e-03 | 2.742 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.036157e-03 | 2.691 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.310218e-03 | 2.636 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.849157e-03 | 2.545 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.219688e-03 | 2.492 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.091174e-03 | 2.510 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.231833e-03 | 2.491 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.314923e-03 | 2.480 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.337791e-03 | 2.477 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.110429e-03 | 2.386 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.963604e-03 | 2.402 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.968593e-03 | 2.401 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.912028e-03 | 2.408 | 1 | 0 |
| Gap junction assembly | R-HSA-190861 | 4.110429e-03 | 2.386 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.301605e-03 | 2.276 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.301605e-03 | 2.276 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.663677e-03 | 2.247 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.663677e-03 | 2.247 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.663677e-03 | 2.247 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.760907e-03 | 2.240 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 5.964018e-03 | 2.224 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.380078e-03 | 2.195 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.468190e-03 | 2.127 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 7.731202e-03 | 2.112 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 7.805186e-03 | 2.108 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.674878e-03 | 2.062 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.169192e-03 | 2.088 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 8.710920e-03 | 2.060 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.803622e-03 | 2.055 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.413768e-03 | 2.026 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 9.451190e-03 | 2.025 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 9.451974e-03 | 2.024 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.052939e-02 | 1.978 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.173221e-02 | 1.931 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.173221e-02 | 1.931 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.181424e-02 | 1.928 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.156294e-02 | 1.937 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.183403e-02 | 1.927 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.210667e-02 | 1.917 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.210667e-02 | 1.917 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.472905e-02 | 1.832 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.472905e-02 | 1.832 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.472905e-02 | 1.832 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.441101e-02 | 1.841 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.441101e-02 | 1.841 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.292792e-02 | 1.888 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.347721e-02 | 1.870 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.299360e-02 | 1.886 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.472905e-02 | 1.832 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.344125e-02 | 1.872 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.273873e-02 | 1.895 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.469559e-02 | 1.833 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.417121e-02 | 1.849 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.423907e-02 | 1.847 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.302515e-02 | 1.885 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.459988e-02 | 1.836 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.234847e-02 | 1.908 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.273873e-02 | 1.895 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.246134e-02 | 1.904 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.589248e-02 | 1.799 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.747207e-02 | 1.758 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.582618e-02 | 1.801 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 1.747207e-02 | 1.758 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.747207e-02 | 1.758 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.747207e-02 | 1.758 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.747207e-02 | 1.758 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.712191e-02 | 1.766 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.589248e-02 | 1.799 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.734614e-02 | 1.761 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.747207e-02 | 1.758 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.764748e-02 | 1.753 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.764748e-02 | 1.753 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.764748e-02 | 1.753 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.764748e-02 | 1.753 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.848879e-02 | 1.733 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.086457e-02 | 1.681 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.086457e-02 | 1.681 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.086457e-02 | 1.681 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.086457e-02 | 1.681 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.086457e-02 | 1.681 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.086457e-02 | 1.681 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.951457e-02 | 1.710 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.888677e-02 | 1.724 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.061876e-02 | 1.686 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.093508e-02 | 1.679 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.183879e-02 | 1.661 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.241812e-02 | 1.649 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.241812e-02 | 1.649 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.282284e-02 | 1.642 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.445855e-02 | 1.612 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.469966e-02 | 1.607 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.692060e-02 | 1.570 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.913400e-02 | 1.536 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.913400e-02 | 1.536 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.696779e-02 | 1.569 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.692060e-02 | 1.570 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.699068e-02 | 1.569 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.549960e-02 | 1.593 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.696779e-02 | 1.569 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.913400e-02 | 1.536 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.692060e-02 | 1.570 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.116383e-02 | 1.506 | 1 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 3.543818e-02 | 1.451 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 3.440754e-02 | 1.463 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.231227e-02 | 1.491 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.280470e-02 | 1.484 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.596490e-02 | 1.444 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 3.145910e-02 | 1.502 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.145910e-02 | 1.502 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.145910e-02 | 1.502 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.440754e-02 | 1.463 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.231227e-02 | 1.491 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.280470e-02 | 1.484 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.596490e-02 | 1.444 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.231227e-02 | 1.491 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.440754e-02 | 1.463 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.644945e-02 | 1.438 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.502322e-02 | 1.456 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.145910e-02 | 1.502 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.286916e-02 | 1.483 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.424111e-02 | 1.465 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.644945e-02 | 1.438 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.644945e-02 | 1.438 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.671977e-02 | 1.435 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.898728e-02 | 1.409 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.929488e-02 | 1.406 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.009023e-02 | 1.397 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.029180e-02 | 1.395 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 4.254170e-02 | 1.371 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 4.254170e-02 | 1.371 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 4.254170e-02 | 1.371 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.270513e-02 | 1.370 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.131190e-02 | 1.290 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.131190e-02 | 1.290 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.131190e-02 | 1.290 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.279490e-02 | 1.369 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.080788e-02 | 1.294 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.781700e-02 | 1.320 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 4.641282e-02 | 1.333 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 5.131190e-02 | 1.290 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.582854e-02 | 1.339 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.338513e-02 | 1.363 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 5.131190e-02 | 1.290 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.706112e-02 | 1.327 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.080788e-02 | 1.294 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 5.030448e-02 | 1.298 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.338513e-02 | 1.363 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 5.168378e-02 | 1.287 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.168378e-02 | 1.287 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.245689e-02 | 1.280 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.366265e-02 | 1.270 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.392664e-02 | 1.268 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.392664e-02 | 1.268 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 5.420344e-02 | 1.266 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 5.431289e-02 | 1.265 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.431289e-02 | 1.265 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 6.962258e-02 | 1.157 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.066300e-02 | 1.217 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.066300e-02 | 1.217 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.283171e-02 | 1.202 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.912483e-02 | 1.160 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.468919e-02 | 1.189 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.901718e-02 | 1.161 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.973078e-02 | 1.224 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.468919e-02 | 1.189 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.723065e-02 | 1.242 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.466468e-02 | 1.189 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 5.929573e-02 | 1.227 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.066300e-02 | 1.217 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.912483e-02 | 1.160 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.066300e-02 | 1.217 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.919459e-02 | 1.228 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.471626e-02 | 1.189 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.780934e-02 | 1.238 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.283171e-02 | 1.202 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.895367e-02 | 1.229 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.971167e-02 | 1.157 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.054298e-02 | 1.152 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 7.054298e-02 | 1.152 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 7.054298e-02 | 1.152 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 7.054298e-02 | 1.152 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.054298e-02 | 1.152 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.200951e-02 | 1.143 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.545717e-02 | 1.122 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.545717e-02 | 1.122 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.545717e-02 | 1.122 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.617642e-02 | 1.118 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 7.684062e-02 | 1.114 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 7.684062e-02 | 1.114 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 7.684062e-02 | 1.114 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 1.025975e-01 | 0.989 | 0 | 0 |
| Defective SLC12A3 causes Gitelman syndrome (GS) | R-HSA-5619087 | 1.025975e-01 | 0.989 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 1.025975e-01 | 0.989 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.025975e-01 | 0.989 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 1.025975e-01 | 0.989 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.025975e-01 | 0.989 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.090275e-02 | 1.092 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 8.090275e-02 | 1.092 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.885165e-02 | 1.051 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.031610e-01 | 0.986 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.031610e-01 | 0.986 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 8.024418e-02 | 1.096 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.022658e-01 | 0.990 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.495374e-02 | 1.071 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 9.169603e-02 | 1.038 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.031610e-01 | 0.986 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 9.169603e-02 | 1.038 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 1.028792e-01 | 0.988 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.596829e-02 | 1.018 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.024418e-02 | 1.096 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.025975e-01 | 0.989 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.025975e-01 | 0.989 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 8.090275e-02 | 1.092 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 9.169603e-02 | 1.038 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.028792e-01 | 0.988 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.028792e-01 | 0.988 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 9.227340e-02 | 1.035 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 9.158453e-02 | 1.038 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.031610e-01 | 0.986 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.885165e-02 | 1.051 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.030306e-02 | 1.095 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 8.090275e-02 | 1.092 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 9.764132e-02 | 1.010 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 9.764132e-02 | 1.010 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.212271e-02 | 1.086 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 8.090275e-02 | 1.092 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.030774e-01 | 0.987 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.030774e-01 | 0.987 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.030774e-01 | 0.987 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.645117e-02 | 1.016 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 1.025975e-01 | 0.989 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.885165e-02 | 1.051 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.794924e-02 | 1.108 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.794924e-02 | 1.108 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.603461e-02 | 1.065 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.442571e-02 | 1.074 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.183008e-02 | 1.087 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.442571e-02 | 1.074 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.183008e-02 | 1.087 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 8.285965e-02 | 1.082 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.022658e-01 | 0.990 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.885165e-02 | 1.051 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.495374e-02 | 1.071 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.719880e-02 | 1.012 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.033160e-01 | 0.986 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.055474e-01 | 0.977 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.055474e-01 | 0.977 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.067364e-01 | 0.972 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.069974e-01 | 0.971 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 1.344056e-01 | 0.872 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.344056e-01 | 0.872 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 1.344056e-01 | 0.872 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.344056e-01 | 0.872 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 1.650882e-01 | 0.782 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.650882e-01 | 0.782 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 1.650882e-01 | 0.782 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 1.650882e-01 | 0.782 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.650882e-01 | 0.782 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.650882e-01 | 0.782 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 1.650882e-01 | 0.782 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.946850e-01 | 0.711 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.946850e-01 | 0.711 | 0 | 0 |
| Defective MAT1A causes MATD | R-HSA-5579024 | 1.946850e-01 | 0.711 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 1.946850e-01 | 0.711 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 1.946850e-01 | 0.711 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.946850e-01 | 0.711 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 2.232343e-01 | 0.651 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.232343e-01 | 0.651 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.232343e-01 | 0.651 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.232343e-01 | 0.651 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 2.232343e-01 | 0.651 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.232343e-01 | 0.651 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.144112e-01 | 0.942 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.507732e-01 | 0.601 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.507732e-01 | 0.601 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 2.507732e-01 | 0.601 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.262534e-01 | 0.899 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.383693e-01 | 0.859 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.507249e-01 | 0.822 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.029613e-01 | 0.519 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.029613e-01 | 0.519 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.029613e-01 | 0.519 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.029613e-01 | 0.519 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 3.029613e-01 | 0.519 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 1.889177e-01 | 0.724 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.276782e-01 | 0.485 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.282237e-01 | 0.642 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.333651e-01 | 0.875 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.333651e-01 | 0.875 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.333651e-01 | 0.875 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.547304e-01 | 0.594 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 2.547304e-01 | 0.594 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.167752e-01 | 0.933 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.167752e-01 | 0.933 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.040213e-01 | 0.690 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.269605e-01 | 0.896 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.132784e-01 | 0.671 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.540994e-01 | 0.812 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.714415e-01 | 0.766 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.607130e-01 | 0.584 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.834035e-01 | 0.737 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.563879e-01 | 0.806 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.614068e-01 | 0.792 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.821524e-01 | 0.740 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.874981e-01 | 0.727 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.322872e-01 | 0.634 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.618289e-01 | 0.582 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.678537e-01 | 0.572 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.493634e-01 | 0.826 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.277975e-01 | 0.893 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.414608e-01 | 0.617 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.274648e-01 | 0.643 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.106360e-01 | 0.956 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.232992e-01 | 0.909 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.879524e-01 | 0.541 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.265087e-01 | 0.645 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.383693e-01 | 0.859 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.424508e-01 | 0.846 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.265876e-01 | 0.898 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.507249e-01 | 0.822 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.462818e-01 | 0.835 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.019297e-01 | 0.695 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.276782e-01 | 0.485 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.607130e-01 | 0.584 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.648755e-01 | 0.783 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.648755e-01 | 0.783 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.333651e-01 | 0.875 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.246611e-01 | 0.648 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.714415e-01 | 0.766 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.796669e-01 | 0.746 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 1.507249e-01 | 0.822 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.183120e-01 | 0.927 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.508352e-01 | 0.821 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.714415e-01 | 0.766 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.439797e-01 | 0.613 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.439797e-01 | 0.613 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.144112e-01 | 0.942 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.128653e-01 | 0.505 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.871173e-01 | 0.542 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.040213e-01 | 0.690 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 1.946850e-01 | 0.711 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 2.232343e-01 | 0.651 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.232343e-01 | 0.651 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.232343e-01 | 0.651 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 2.232343e-01 | 0.651 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.507249e-01 | 0.822 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.183120e-01 | 0.927 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.019297e-01 | 0.695 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.397634e-01 | 0.855 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 3.077756e-01 | 0.512 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.678537e-01 | 0.572 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.612767e-01 | 0.583 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.829563e-01 | 0.548 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.632879e-01 | 0.787 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.870829e-01 | 0.542 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.322769e-01 | 0.634 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.322769e-01 | 0.634 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.322769e-01 | 0.634 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.322769e-01 | 0.634 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.540994e-01 | 0.812 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 1.946850e-01 | 0.711 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.507732e-01 | 0.601 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 1.507249e-01 | 0.822 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.282237e-01 | 0.642 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.874981e-01 | 0.727 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.739130e-01 | 0.562 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.945521e-01 | 0.531 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.945521e-01 | 0.531 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.145589e-01 | 0.668 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.773374e-01 | 0.557 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.150395e-01 | 0.667 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.040213e-01 | 0.690 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.597966e-01 | 0.796 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.022317e-01 | 0.694 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.019297e-01 | 0.695 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.336883e-01 | 0.874 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.950739e-01 | 0.530 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.415433e-01 | 0.617 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 1.344056e-01 | 0.872 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.946850e-01 | 0.711 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.946850e-01 | 0.711 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.144112e-01 | 0.942 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.507732e-01 | 0.601 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.507732e-01 | 0.601 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 2.507732e-01 | 0.601 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.507732e-01 | 0.601 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.262534e-01 | 0.899 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 2.773374e-01 | 0.557 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.632879e-01 | 0.787 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 3.029613e-01 | 0.519 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.276782e-01 | 0.485 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.276782e-01 | 0.485 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.209452e-01 | 0.917 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.734706e-01 | 0.761 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 3.209495e-01 | 0.494 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.773842e-01 | 0.751 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.462310e-01 | 0.835 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.029613e-01 | 0.519 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 2.341209e-01 | 0.631 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.894970e-01 | 0.722 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.716489e-01 | 0.765 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.232343e-01 | 0.651 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.106360e-01 | 0.956 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.276782e-01 | 0.485 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.415433e-01 | 0.617 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.415433e-01 | 0.617 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.191977e-01 | 0.496 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.941416e-01 | 0.531 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 2.995491e-01 | 0.524 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.322769e-01 | 0.634 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 2.232343e-01 | 0.651 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.029613e-01 | 0.519 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.029613e-01 | 0.519 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.276782e-01 | 0.485 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.188805e-01 | 0.925 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.381115e-01 | 0.623 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.112154e-01 | 0.954 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 3.276782e-01 | 0.485 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.618289e-01 | 0.582 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.144112e-01 | 0.942 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.734706e-01 | 0.761 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.309549e-01 | 0.636 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.123309e-01 | 0.950 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.288743e-01 | 0.640 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.997266e-01 | 0.523 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.041381e-01 | 0.517 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.229383e-01 | 0.910 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.123309e-01 | 0.950 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.229383e-01 | 0.910 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 2.399550e-01 | 0.620 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.555759e-01 | 0.592 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.664943e-01 | 0.779 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.618289e-01 | 0.582 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.946850e-01 | 0.711 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.946850e-01 | 0.711 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.232343e-01 | 0.651 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.507732e-01 | 0.601 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.507732e-01 | 0.601 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.507249e-01 | 0.822 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.029613e-01 | 0.519 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.029613e-01 | 0.519 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.276782e-01 | 0.485 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.276782e-01 | 0.485 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.019297e-01 | 0.695 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.149315e-01 | 0.940 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.680532e-01 | 0.775 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.812931e-01 | 0.551 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.945521e-01 | 0.531 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.805246e-01 | 0.743 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 3.093181e-01 | 0.510 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.405913e-01 | 0.619 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.804745e-01 | 0.744 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.104127e-01 | 0.957 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.313637e-01 | 0.636 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.508352e-01 | 0.821 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.260662e-01 | 0.487 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.513838e-01 | 0.820 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.507732e-01 | 0.601 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.262534e-01 | 0.899 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.703715e-01 | 0.568 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.507249e-01 | 0.822 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.150395e-01 | 0.667 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.607130e-01 | 0.584 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 2.207779e-01 | 0.656 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.680532e-01 | 0.775 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.856194e-01 | 0.731 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.069090e-01 | 0.513 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.760283e-01 | 0.754 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.694885e-01 | 0.771 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.818441e-01 | 0.740 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.554800e-01 | 0.593 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.836590e-01 | 0.736 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.836590e-01 | 0.736 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.554800e-01 | 0.593 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.554800e-01 | 0.593 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.733116e-01 | 0.761 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.096814e-01 | 0.678 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 1.946850e-01 | 0.711 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.946850e-01 | 0.711 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.232343e-01 | 0.651 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.383693e-01 | 0.859 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.632879e-01 | 0.787 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.029613e-01 | 0.519 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.029613e-01 | 0.519 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.276782e-01 | 0.485 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.834035e-01 | 0.737 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.574186e-01 | 0.803 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.381115e-01 | 0.623 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.606605e-01 | 0.584 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.479415e-01 | 0.606 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.167900e-01 | 0.499 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.209495e-01 | 0.494 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 3.190972e-01 | 0.496 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.994382e-01 | 0.700 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.593655e-01 | 0.798 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.149315e-01 | 0.940 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.703145e-01 | 0.568 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.730709e-01 | 0.762 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.065177e-01 | 0.514 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.572860e-01 | 0.803 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.703715e-01 | 0.568 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.770888e-01 | 0.557 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.678537e-01 | 0.572 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.538283e-01 | 0.595 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.496376e-01 | 0.825 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.019297e-01 | 0.695 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.232343e-01 | 0.651 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 2.507732e-01 | 0.601 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.507732e-01 | 0.601 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.507732e-01 | 0.601 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 2.507732e-01 | 0.601 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.632879e-01 | 0.787 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 3.029613e-01 | 0.519 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 1.760283e-01 | 0.754 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.276782e-01 | 0.485 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.680532e-01 | 0.775 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.470058e-01 | 0.833 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.342291e-01 | 0.872 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.104642e-01 | 0.957 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.514391e-01 | 0.820 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.118344e-01 | 0.951 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.609822e-01 | 0.793 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.609822e-01 | 0.793 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.505873e-01 | 0.822 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.648755e-01 | 0.783 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 1.183120e-01 | 0.927 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.547304e-01 | 0.594 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.156514e-01 | 0.666 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.399550e-01 | 0.620 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 2.154142e-01 | 0.667 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.262534e-01 | 0.899 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 2.320480e-01 | 0.634 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.245706e-01 | 0.649 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.270910e-01 | 0.896 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 2.232343e-01 | 0.651 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.507732e-01 | 0.601 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.111353e-01 | 0.507 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 2.897969e-01 | 0.538 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.497039e-01 | 0.825 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.019297e-01 | 0.695 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.837100e-01 | 0.736 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 2.791238e-01 | 0.554 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.138581e-01 | 0.670 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.029613e-01 | 0.519 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.760283e-01 | 0.754 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.019297e-01 | 0.695 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.077756e-01 | 0.512 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.540994e-01 | 0.812 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.209829e-01 | 0.656 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 3.272759e-01 | 0.485 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 2.870829e-01 | 0.542 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.019297e-01 | 0.695 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.734706e-01 | 0.761 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 3.077756e-01 | 0.512 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.547304e-01 | 0.594 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 2.547304e-01 | 0.594 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 1.368871e-01 | 0.864 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.511010e-01 | 0.600 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.272759e-01 | 0.485 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.463522e-01 | 0.835 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.209495e-01 | 0.494 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.680532e-01 | 0.775 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.948618e-01 | 0.530 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.629580e-01 | 0.580 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.282303e-01 | 0.484 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.296791e-01 | 0.482 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.296791e-01 | 0.482 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.297003e-01 | 0.482 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 3.340606e-01 | 0.476 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.340606e-01 | 0.476 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.340606e-01 | 0.476 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.386592e-01 | 0.470 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 3.386592e-01 | 0.470 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.438570e-01 | 0.464 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 3.438570e-01 | 0.464 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.470970e-01 | 0.460 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.470970e-01 | 0.460 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 3.470970e-01 | 0.460 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.488101e-01 | 0.457 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.509153e-01 | 0.455 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.515201e-01 | 0.454 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.515201e-01 | 0.454 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.515201e-01 | 0.454 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.515201e-01 | 0.454 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.515201e-01 | 0.454 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.515201e-01 | 0.454 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.515201e-01 | 0.454 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.515201e-01 | 0.454 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.515201e-01 | 0.454 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 3.515201e-01 | 0.454 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 3.515201e-01 | 0.454 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.515201e-01 | 0.454 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.515201e-01 | 0.454 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.515201e-01 | 0.454 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.515201e-01 | 0.454 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.515201e-01 | 0.454 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.581849e-01 | 0.446 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.596722e-01 | 0.444 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.600473e-01 | 0.444 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.600473e-01 | 0.444 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.600473e-01 | 0.444 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.600473e-01 | 0.444 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.612907e-01 | 0.442 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.650512e-01 | 0.438 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.679196e-01 | 0.434 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.679196e-01 | 0.434 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 3.679196e-01 | 0.434 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 3.708168e-01 | 0.431 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 3.722159e-01 | 0.429 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.729015e-01 | 0.428 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 3.729015e-01 | 0.428 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.729015e-01 | 0.428 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.729015e-01 | 0.428 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.739935e-01 | 0.427 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.745178e-01 | 0.427 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.745178e-01 | 0.427 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 3.745178e-01 | 0.427 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 3.745178e-01 | 0.427 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.745178e-01 | 0.427 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 3.745178e-01 | 0.427 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.745178e-01 | 0.427 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.745178e-01 | 0.427 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 3.745178e-01 | 0.427 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.745178e-01 | 0.427 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.745178e-01 | 0.427 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.758699e-01 | 0.425 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.758699e-01 | 0.425 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.758699e-01 | 0.425 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.791970e-01 | 0.421 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.803503e-01 | 0.420 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.856499e-01 | 0.414 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.861465e-01 | 0.413 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.862679e-01 | 0.413 | 1 | 1 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.862679e-01 | 0.413 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.873051e-01 | 0.412 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.873051e-01 | 0.412 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.920307e-01 | 0.407 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.967014e-01 | 0.402 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.967014e-01 | 0.402 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.967014e-01 | 0.402 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 3.967014e-01 | 0.402 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.967014e-01 | 0.402 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 3.969457e-01 | 0.401 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.036216e-01 | 0.394 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.065450e-01 | 0.391 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.065450e-01 | 0.391 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.107960e-01 | 0.386 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.107960e-01 | 0.386 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.107960e-01 | 0.386 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.107960e-01 | 0.386 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.160986e-01 | 0.381 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 4.160986e-01 | 0.381 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.160986e-01 | 0.381 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 4.180995e-01 | 0.379 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.180995e-01 | 0.379 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.180995e-01 | 0.379 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.180995e-01 | 0.379 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.180995e-01 | 0.379 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.210807e-01 | 0.376 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.231785e-01 | 0.373 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.231785e-01 | 0.373 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 4.231785e-01 | 0.373 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.256019e-01 | 0.371 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.268911e-01 | 0.370 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.321073e-01 | 0.364 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 4.354250e-01 | 0.361 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.354250e-01 | 0.361 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.374282e-01 | 0.359 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.387398e-01 | 0.358 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 4.387398e-01 | 0.358 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.387398e-01 | 0.358 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.387398e-01 | 0.358 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.387398e-01 | 0.358 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 4.387398e-01 | 0.358 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 4.387398e-01 | 0.358 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 4.387398e-01 | 0.358 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.387398e-01 | 0.358 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 4.400436e-01 | 0.357 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.444415e-01 | 0.352 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 4.444415e-01 | 0.352 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.444415e-01 | 0.352 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.475296e-01 | 0.349 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.500545e-01 | 0.347 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.511544e-01 | 0.346 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.537700e-01 | 0.343 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 4.586493e-01 | 0.339 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.586493e-01 | 0.339 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.586493e-01 | 0.339 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.586493e-01 | 0.339 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.586493e-01 | 0.339 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 4.586493e-01 | 0.339 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.586493e-01 | 0.339 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.586493e-01 | 0.339 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.594870e-01 | 0.338 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 4.594870e-01 | 0.338 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.712924e-01 | 0.327 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.712924e-01 | 0.327 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.722268e-01 | 0.326 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 4.778537e-01 | 0.321 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.778537e-01 | 0.321 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.778537e-01 | 0.321 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 4.778537e-01 | 0.321 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 4.778537e-01 | 0.321 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.778537e-01 | 0.321 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 4.778537e-01 | 0.321 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 4.778537e-01 | 0.321 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.813486e-01 | 0.318 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 4.829415e-01 | 0.316 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 4.829415e-01 | 0.316 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.829415e-01 | 0.316 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 4.856495e-01 | 0.314 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.934886e-01 | 0.307 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.944306e-01 | 0.306 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 4.944306e-01 | 0.306 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.963779e-01 | 0.304 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.963779e-01 | 0.304 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 4.963779e-01 | 0.304 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.963779e-01 | 0.304 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 4.963779e-01 | 0.304 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.963779e-01 | 0.304 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.963779e-01 | 0.304 | 0 | 0 |
| Synthesis of 12-eicosatetraenoic acid derivatives | R-HSA-2142712 | 4.963779e-01 | 0.304 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 4.963779e-01 | 0.304 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 4.963779e-01 | 0.304 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.963779e-01 | 0.304 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 4.963779e-01 | 0.304 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.963779e-01 | 0.304 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.963779e-01 | 0.304 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 4.963779e-01 | 0.304 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 4.963779e-01 | 0.304 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 4.963779e-01 | 0.304 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.029473e-01 | 0.298 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.057563e-01 | 0.296 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.057563e-01 | 0.296 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 5.057563e-01 | 0.296 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.082515e-01 | 0.294 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.087510e-01 | 0.293 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.142461e-01 | 0.289 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.142461e-01 | 0.289 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.142461e-01 | 0.289 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.142461e-01 | 0.289 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.142461e-01 | 0.289 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.142461e-01 | 0.289 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.142461e-01 | 0.289 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.142461e-01 | 0.289 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.142461e-01 | 0.289 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.142461e-01 | 0.289 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.169159e-01 | 0.287 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.169159e-01 | 0.287 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.170563e-01 | 0.286 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.174856e-01 | 0.286 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.178204e-01 | 0.286 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.195325e-01 | 0.284 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.238335e-01 | 0.281 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 5.246730e-01 | 0.280 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.279068e-01 | 0.277 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 5.279068e-01 | 0.277 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 5.279068e-01 | 0.277 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.314814e-01 | 0.275 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.314814e-01 | 0.275 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.314814e-01 | 0.275 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 5.314814e-01 | 0.275 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 5.314814e-01 | 0.275 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 5.314814e-01 | 0.275 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.314814e-01 | 0.275 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.314814e-01 | 0.275 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.314814e-01 | 0.275 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.314814e-01 | 0.275 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.314814e-01 | 0.275 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 5.314814e-01 | 0.275 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 5.314814e-01 | 0.275 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 5.320698e-01 | 0.274 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.344075e-01 | 0.272 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.394092e-01 | 0.268 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.429498e-01 | 0.265 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.429498e-01 | 0.265 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.429498e-01 | 0.265 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.457046e-01 | 0.263 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 5.481061e-01 | 0.261 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 5.481061e-01 | 0.261 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.493747e-01 | 0.260 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.514008e-01 | 0.259 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.514008e-01 | 0.259 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.539106e-01 | 0.257 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.594693e-01 | 0.252 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.641419e-01 | 0.249 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.641419e-01 | 0.249 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 5.641419e-01 | 0.249 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.641419e-01 | 0.249 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.641419e-01 | 0.249 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.641419e-01 | 0.249 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 5.680220e-01 | 0.246 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.680220e-01 | 0.246 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.701476e-01 | 0.244 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.701476e-01 | 0.244 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.701476e-01 | 0.244 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.751985e-01 | 0.240 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.761892e-01 | 0.239 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 5.761892e-01 | 0.239 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.764845e-01 | 0.239 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.764845e-01 | 0.239 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 5.796096e-01 | 0.237 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 5.796096e-01 | 0.237 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.796096e-01 | 0.237 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.796096e-01 | 0.237 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.796096e-01 | 0.237 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.796096e-01 | 0.237 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 5.796096e-01 | 0.237 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.796096e-01 | 0.237 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 5.796096e-01 | 0.237 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 5.796096e-01 | 0.237 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 5.796096e-01 | 0.237 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.802710e-01 | 0.236 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.802710e-01 | 0.236 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.817358e-01 | 0.235 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 5.821555e-01 | 0.235 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.842592e-01 | 0.233 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.939377e-01 | 0.226 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 5.945293e-01 | 0.226 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 5.945293e-01 | 0.226 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 5.945293e-01 | 0.226 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 5.945293e-01 | 0.226 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 5.945293e-01 | 0.226 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.945293e-01 | 0.226 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 5.945293e-01 | 0.226 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.945293e-01 | 0.226 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 5.945293e-01 | 0.226 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 5.959012e-01 | 0.225 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 5.999888e-01 | 0.222 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.001029e-01 | 0.222 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.044454e-01 | 0.219 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 6.065879e-01 | 0.217 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.078747e-01 | 0.216 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.089204e-01 | 0.215 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.089204e-01 | 0.215 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 6.089204e-01 | 0.215 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.089204e-01 | 0.215 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.089204e-01 | 0.215 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.089204e-01 | 0.215 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 6.089204e-01 | 0.215 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.089204e-01 | 0.215 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 6.089204e-01 | 0.215 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.095831e-01 | 0.215 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.095831e-01 | 0.215 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.099161e-01 | 0.215 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.145709e-01 | 0.211 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.190011e-01 | 0.208 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 6.190011e-01 | 0.208 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.228016e-01 | 0.206 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.228016e-01 | 0.206 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.228016e-01 | 0.206 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.228016e-01 | 0.206 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 6.228016e-01 | 0.206 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.228016e-01 | 0.206 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.228016e-01 | 0.206 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.231141e-01 | 0.205 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.238232e-01 | 0.205 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.282433e-01 | 0.202 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 6.361909e-01 | 0.196 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.361909e-01 | 0.196 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.361909e-01 | 0.196 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.361909e-01 | 0.196 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.361909e-01 | 0.196 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.361909e-01 | 0.196 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.361909e-01 | 0.196 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.361909e-01 | 0.196 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 6.361909e-01 | 0.196 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.361909e-01 | 0.196 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.361909e-01 | 0.196 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.379441e-01 | 0.195 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.462030e-01 | 0.190 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.462030e-01 | 0.190 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.462030e-01 | 0.190 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.467575e-01 | 0.189 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 6.491056e-01 | 0.188 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 6.491056e-01 | 0.188 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 6.491056e-01 | 0.188 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.491056e-01 | 0.188 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 6.491056e-01 | 0.188 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 6.491056e-01 | 0.188 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.491056e-01 | 0.188 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.501097e-01 | 0.187 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 6.615627e-01 | 0.179 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.615627e-01 | 0.179 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.615627e-01 | 0.179 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.615627e-01 | 0.179 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.615627e-01 | 0.179 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 6.615627e-01 | 0.179 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 6.615627e-01 | 0.179 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 6.615627e-01 | 0.179 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.634690e-01 | 0.178 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 6.664326e-01 | 0.176 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.718448e-01 | 0.173 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.718448e-01 | 0.173 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.718448e-01 | 0.173 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.718448e-01 | 0.173 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.718448e-01 | 0.173 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 6.724083e-01 | 0.172 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.732090e-01 | 0.172 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.735783e-01 | 0.172 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 6.735783e-01 | 0.172 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.741188e-01 | 0.171 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.800507e-01 | 0.167 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.850844e-01 | 0.164 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.851680e-01 | 0.164 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 6.851680e-01 | 0.164 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 6.880885e-01 | 0.162 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.931233e-01 | 0.159 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.955679e-01 | 0.158 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.959596e-01 | 0.157 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.959596e-01 | 0.157 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 6.963469e-01 | 0.157 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 6.963469e-01 | 0.157 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 6.963469e-01 | 0.157 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 6.963469e-01 | 0.157 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.963469e-01 | 0.157 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.963469e-01 | 0.157 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 6.963469e-01 | 0.157 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.011714e-01 | 0.154 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.067004e-01 | 0.151 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 7.068742e-01 | 0.151 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.071295e-01 | 0.151 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.071295e-01 | 0.151 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.112087e-01 | 0.148 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 7.175299e-01 | 0.144 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.175299e-01 | 0.144 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.175299e-01 | 0.144 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 7.180613e-01 | 0.144 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.182337e-01 | 0.144 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.185903e-01 | 0.144 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.185903e-01 | 0.144 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.185903e-01 | 0.144 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.185903e-01 | 0.144 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.197299e-01 | 0.143 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 7.242564e-01 | 0.140 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.275615e-01 | 0.138 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.275615e-01 | 0.138 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.275615e-01 | 0.138 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.275615e-01 | 0.138 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.275615e-01 | 0.138 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 7.275615e-01 | 0.138 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.328775e-01 | 0.135 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.328775e-01 | 0.135 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.372375e-01 | 0.132 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.397871e-01 | 0.131 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 7.397871e-01 | 0.131 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.433233e-01 | 0.129 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.465704e-01 | 0.127 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.465704e-01 | 0.127 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.465704e-01 | 0.127 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.465704e-01 | 0.127 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.465704e-01 | 0.127 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 7.473447e-01 | 0.126 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.528695e-01 | 0.123 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.531245e-01 | 0.123 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.555723e-01 | 0.122 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.555723e-01 | 0.122 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.555723e-01 | 0.122 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.555723e-01 | 0.122 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.555723e-01 | 0.122 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 7.555723e-01 | 0.122 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 7.555723e-01 | 0.122 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 7.582968e-01 | 0.120 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.642551e-01 | 0.117 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 7.642551e-01 | 0.117 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.642551e-01 | 0.117 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 7.642551e-01 | 0.117 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 7.720810e-01 | 0.112 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.720810e-01 | 0.112 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 7.726299e-01 | 0.112 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.726299e-01 | 0.112 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.726299e-01 | 0.112 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 7.726299e-01 | 0.112 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 7.726299e-01 | 0.112 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.726299e-01 | 0.112 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.740027e-01 | 0.111 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 7.781046e-01 | 0.109 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 7.781046e-01 | 0.109 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 7.798265e-01 | 0.108 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 7.807076e-01 | 0.108 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.807076e-01 | 0.108 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 7.807076e-01 | 0.108 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.807076e-01 | 0.108 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.807076e-01 | 0.108 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.808004e-01 | 0.107 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 7.839884e-01 | 0.106 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.840021e-01 | 0.106 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.884989e-01 | 0.103 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.884989e-01 | 0.103 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.884989e-01 | 0.103 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 7.884989e-01 | 0.103 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.889225e-01 | 0.103 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.897347e-01 | 0.103 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.897347e-01 | 0.103 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.936332e-01 | 0.100 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 7.960138e-01 | 0.099 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.960138e-01 | 0.099 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.960138e-01 | 0.099 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 7.960138e-01 | 0.099 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 7.960138e-01 | 0.099 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.983132e-01 | 0.098 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 8.008245e-01 | 0.096 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.019373e-01 | 0.096 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 8.036003e-01 | 0.095 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.059607e-01 | 0.094 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 8.061726e-01 | 0.094 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 8.074071e-01 | 0.093 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.102534e-01 | 0.091 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.102534e-01 | 0.091 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.102534e-01 | 0.091 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 8.102534e-01 | 0.091 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.115651e-01 | 0.091 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.150297e-01 | 0.089 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.151910e-01 | 0.089 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.161532e-01 | 0.088 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 8.169966e-01 | 0.088 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.169966e-01 | 0.088 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.169966e-01 | 0.088 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.176339e-01 | 0.087 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.176339e-01 | 0.087 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.176339e-01 | 0.087 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 8.214577e-01 | 0.085 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.235005e-01 | 0.084 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.235005e-01 | 0.084 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.235005e-01 | 0.084 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.235005e-01 | 0.084 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.263075e-01 | 0.083 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.263075e-01 | 0.083 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 8.280002e-01 | 0.082 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.297737e-01 | 0.081 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 8.326369e-01 | 0.080 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.358025e-01 | 0.078 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.358243e-01 | 0.078 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.358243e-01 | 0.078 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.358243e-01 | 0.078 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.358243e-01 | 0.078 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.416602e-01 | 0.075 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.416602e-01 | 0.075 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.416602e-01 | 0.075 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.416602e-01 | 0.075 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.426350e-01 | 0.074 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 8.441522e-01 | 0.074 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.472890e-01 | 0.072 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.472890e-01 | 0.072 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.472890e-01 | 0.072 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.472890e-01 | 0.072 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.472890e-01 | 0.072 | 0 | 0 |
| Methylation | R-HSA-156581 | 8.472890e-01 | 0.072 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 8.472890e-01 | 0.072 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.527180e-01 | 0.069 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.527180e-01 | 0.069 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 8.527180e-01 | 0.069 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.527180e-01 | 0.069 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.527180e-01 | 0.069 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.527180e-01 | 0.069 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.579543e-01 | 0.067 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.579543e-01 | 0.067 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.579543e-01 | 0.067 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.579543e-01 | 0.067 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.630048e-01 | 0.064 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.630048e-01 | 0.064 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 8.678760e-01 | 0.062 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.678760e-01 | 0.062 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 8.678760e-01 | 0.062 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.678760e-01 | 0.062 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.704880e-01 | 0.060 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.723175e-01 | 0.059 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.725743e-01 | 0.059 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.725743e-01 | 0.059 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.760686e-01 | 0.057 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.771058e-01 | 0.057 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 8.772148e-01 | 0.057 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.807504e-01 | 0.055 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.814764e-01 | 0.055 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.814764e-01 | 0.055 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.827623e-01 | 0.054 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.840495e-01 | 0.054 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.856918e-01 | 0.053 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.856918e-01 | 0.053 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.856918e-01 | 0.053 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.892806e-01 | 0.051 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.897576e-01 | 0.051 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.897576e-01 | 0.051 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.897576e-01 | 0.051 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 8.897576e-01 | 0.051 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 8.974611e-01 | 0.047 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 8.984304e-01 | 0.047 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 8.997808e-01 | 0.046 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.011089e-01 | 0.045 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.041338e-01 | 0.044 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.046271e-01 | 0.044 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.080204e-01 | 0.042 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.080204e-01 | 0.042 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.112932e-01 | 0.040 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.112932e-01 | 0.040 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.144497e-01 | 0.039 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.144497e-01 | 0.039 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.144497e-01 | 0.039 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.144497e-01 | 0.039 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.174467e-01 | 0.037 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.174467e-01 | 0.037 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.174941e-01 | 0.037 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.174941e-01 | 0.037 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.174941e-01 | 0.037 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.204303e-01 | 0.036 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.204303e-01 | 0.036 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.218235e-01 | 0.035 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 9.228878e-01 | 0.035 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.232622e-01 | 0.035 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.259935e-01 | 0.033 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.259935e-01 | 0.033 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.284230e-01 | 0.032 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.305035e-01 | 0.031 | 0 | 0 |
| Translation | R-HSA-72766 | 9.330298e-01 | 0.030 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.336186e-01 | 0.030 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.364072e-01 | 0.029 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.370248e-01 | 0.028 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.382673e-01 | 0.028 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 9.416259e-01 | 0.026 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.425795e-01 | 0.026 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.425795e-01 | 0.026 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.446242e-01 | 0.025 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.446242e-01 | 0.025 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.460704e-01 | 0.024 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.465962e-01 | 0.024 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.468184e-01 | 0.024 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.468184e-01 | 0.024 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.484982e-01 | 0.023 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.484982e-01 | 0.023 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.503325e-01 | 0.022 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.503325e-01 | 0.022 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.538077e-01 | 0.021 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.538077e-01 | 0.021 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.540314e-01 | 0.020 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.554532e-01 | 0.020 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.554532e-01 | 0.020 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.570402e-01 | 0.019 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.584078e-01 | 0.018 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.588811e-01 | 0.018 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.600468e-01 | 0.018 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.600468e-01 | 0.018 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.628434e-01 | 0.016 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.629747e-01 | 0.016 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.641675e-01 | 0.016 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.654445e-01 | 0.015 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.658231e-01 | 0.015 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.664847e-01 | 0.015 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.678638e-01 | 0.014 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.690093e-01 | 0.014 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.711794e-01 | 0.013 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.733089e-01 | 0.012 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.750751e-01 | 0.011 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.758397e-01 | 0.011 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.759639e-01 | 0.011 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 9.799553e-01 | 0.009 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.820250e-01 | 0.008 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.839918e-01 | 0.007 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.841235e-01 | 0.007 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.848884e-01 | 0.007 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.869851e-01 | 0.006 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.915551e-01 | 0.004 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.916679e-01 | 0.004 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.919691e-01 | 0.004 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.924652e-01 | 0.003 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.924652e-01 | 0.003 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.924888e-01 | 0.003 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.930160e-01 | 0.003 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.941326e-01 | 0.003 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.945868e-01 | 0.002 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.947024e-01 | 0.002 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.951470e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.953205e-01 | 0.002 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.970858e-01 | 0.001 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.974023e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.974811e-01 | 0.001 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.977421e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.979009e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.980489e-01 | 0.001 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.983670e-01 | 0.001 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.986094e-01 | 0.001 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.987856e-01 | 0.001 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.988163e-01 | 0.001 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.990589e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.990912e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.994150e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.994551e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.995205e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.996620e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.997186e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999303e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999605e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999617e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999883e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999964e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular responses to stress | R-HSA-2262752 | 7.771561e-16 | 15.109 | 1 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.770762e-15 | 14.057 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.731948e-14 | 13.761 | 1 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.453282e-13 | 12.838 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.496714e-13 | 12.260 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 6.546985e-13 | 12.184 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 7.605361e-12 | 11.119 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.049105e-11 | 10.979 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.621392e-11 | 10.250 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.884720e-10 | 9.411 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.105635e-10 | 9.292 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.774507e-10 | 9.321 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 8.044310e-10 | 9.095 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.054939e-09 | 8.977 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.558765e-09 | 8.807 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.000937e-09 | 8.699 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.549821e-09 | 8.593 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.397609e-08 | 7.855 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.884200e-08 | 7.725 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.927982e-08 | 7.533 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.508717e-08 | 7.346 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.196686e-08 | 7.284 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.437040e-08 | 7.129 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.923500e-08 | 7.003 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.220059e-07 | 6.914 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.316558e-07 | 6.881 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.778870e-07 | 6.750 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.800803e-07 | 6.745 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.706160e-07 | 6.768 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.427116e-07 | 6.465 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.799183e-07 | 6.420 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.250667e-07 | 6.372 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.550980e-07 | 6.342 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 5.261604e-07 | 6.279 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.910232e-07 | 6.004 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.052917e-06 | 5.978 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.809830e-06 | 5.742 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.907074e-06 | 5.720 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.907074e-06 | 5.720 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.059972e-06 | 5.686 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.336959e-06 | 5.477 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.137219e-06 | 5.503 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.668362e-06 | 5.436 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.742531e-06 | 5.427 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.637879e-06 | 5.439 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.978258e-06 | 5.400 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.876595e-06 | 5.412 | 1 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.123566e-06 | 5.385 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.622297e-06 | 5.335 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.737967e-06 | 5.324 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.256075e-06 | 5.204 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.289783e-06 | 5.201 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.682464e-06 | 5.175 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.682464e-06 | 5.175 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.706037e-06 | 5.174 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 8.232811e-06 | 5.084 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 9.596934e-06 | 5.018 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 9.596934e-06 | 5.018 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 9.596934e-06 | 5.018 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 9.596934e-06 | 5.018 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.970281e-06 | 5.047 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 9.571361e-06 | 5.019 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.167006e-05 | 4.933 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.259902e-05 | 4.900 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.275315e-05 | 4.894 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.275315e-05 | 4.894 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.244679e-05 | 4.905 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.310527e-05 | 4.883 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.395191e-05 | 4.855 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.513262e-05 | 4.820 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.519662e-05 | 4.818 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.691318e-05 | 4.772 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.692984e-05 | 4.771 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.697235e-05 | 4.770 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.706623e-05 | 4.768 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.731397e-05 | 4.762 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.838216e-05 | 4.736 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.897918e-05 | 4.722 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.897918e-05 | 4.722 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.090580e-05 | 4.680 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.296625e-05 | 4.639 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.184313e-05 | 4.497 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.538336e-05 | 4.451 | 1 | 1 |
| PCP/CE pathway | R-HSA-4086400 | 3.549591e-05 | 4.450 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.845032e-05 | 4.415 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.880097e-05 | 4.411 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.314730e-05 | 4.365 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.553185e-05 | 4.342 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.715377e-05 | 4.243 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.715377e-05 | 4.243 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.643805e-05 | 4.248 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.237550e-05 | 4.205 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.259256e-05 | 4.139 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 6.945369e-05 | 4.158 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 7.259256e-05 | 4.139 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.099587e-05 | 4.149 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.099587e-05 | 4.149 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.095470e-05 | 4.092 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 8.095470e-05 | 4.092 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.294556e-05 | 4.081 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 8.418558e-05 | 4.075 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 8.852381e-05 | 4.053 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.436939e-05 | 4.074 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.180540e-04 | 3.928 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.151387e-04 | 3.939 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.162070e-04 | 3.935 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.095416e-04 | 3.960 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.058548e-04 | 3.975 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.054312e-04 | 3.977 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.095416e-04 | 3.960 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.201801e-04 | 3.920 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.255450e-04 | 3.901 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.255450e-04 | 3.901 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.255450e-04 | 3.901 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.290793e-04 | 3.889 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.246236e-04 | 3.904 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.460026e-04 | 3.836 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.429795e-04 | 3.845 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.342938e-04 | 3.872 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.429795e-04 | 3.845 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.429795e-04 | 3.845 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.493815e-04 | 3.826 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.537842e-04 | 3.813 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.537842e-04 | 3.813 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.548453e-04 | 3.810 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.598232e-04 | 3.796 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.679031e-04 | 3.775 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.919213e-04 | 3.717 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.923038e-04 | 3.716 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.002354e-04 | 3.698 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.877358e-04 | 3.726 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.901949e-04 | 3.721 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.821581e-04 | 3.740 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.002686e-04 | 3.698 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.019556e-04 | 3.695 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.068092e-04 | 3.684 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 2.068092e-04 | 3.684 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 2.068092e-04 | 3.684 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.068092e-04 | 3.684 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.068092e-04 | 3.684 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.320903e-04 | 3.634 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.191380e-04 | 3.659 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.191380e-04 | 3.659 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.178454e-04 | 3.662 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.276988e-04 | 3.643 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.153419e-04 | 3.667 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.410988e-04 | 3.618 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.432447e-04 | 3.614 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.490812e-04 | 3.604 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 2.810423e-04 | 3.551 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 2.814583e-04 | 3.551 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.520060e-04 | 3.599 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.749488e-04 | 3.561 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.577064e-04 | 3.589 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.814583e-04 | 3.551 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.810423e-04 | 3.551 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.583620e-04 | 3.588 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.864531e-04 | 3.543 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.194729e-04 | 3.496 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.194729e-04 | 3.496 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.207112e-04 | 3.494 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.393131e-04 | 3.469 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.526368e-04 | 3.453 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.597480e-04 | 3.444 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.727675e-04 | 3.429 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 3.753066e-04 | 3.426 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.989478e-04 | 3.399 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.317931e-04 | 3.365 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.678143e-04 | 3.330 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.367187e-04 | 3.360 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.317931e-04 | 3.365 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.613985e-04 | 3.336 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.849999e-04 | 3.314 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.985134e-04 | 3.302 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.277913e-04 | 3.278 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.463570e-04 | 3.263 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.574618e-04 | 3.254 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 5.696340e-04 | 3.244 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 5.696340e-04 | 3.244 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.748756e-04 | 3.240 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.748756e-04 | 3.240 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.570211e-04 | 3.182 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.581965e-04 | 3.182 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 6.600818e-04 | 3.180 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.600818e-04 | 3.180 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 6.791379e-04 | 3.168 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 6.791379e-04 | 3.168 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.859251e-04 | 3.164 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 7.391675e-04 | 3.131 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.052504e-04 | 3.094 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 7.455098e-04 | 3.128 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 7.350906e-04 | 3.134 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.528718e-04 | 3.123 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.265833e-04 | 3.139 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.003710e-04 | 3.097 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.240406e-04 | 3.140 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.979259e-04 | 3.098 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 7.265833e-04 | 3.139 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.979259e-04 | 3.098 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 7.208921e-04 | 3.142 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.054467e-04 | 3.152 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.621763e-04 | 3.118 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.231778e-04 | 3.141 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.052504e-04 | 3.094 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.003710e-04 | 3.097 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.118857e-04 | 3.091 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.172111e-04 | 3.088 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 8.179947e-04 | 3.087 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.179947e-04 | 3.087 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 8.221644e-04 | 3.085 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.677805e-04 | 3.062 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.677805e-04 | 3.062 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.055792e-04 | 3.043 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.086896e-04 | 3.042 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 9.442018e-04 | 3.025 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.789058e-04 | 3.009 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.789058e-04 | 3.009 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.003253e-03 | 2.999 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.086921e-03 | 2.964 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.086921e-03 | 2.964 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.086921e-03 | 2.964 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.094715e-03 | 2.961 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.105103e-03 | 2.957 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.159035e-03 | 2.936 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 1.159035e-03 | 2.936 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.377214e-03 | 2.861 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 1.377214e-03 | 2.861 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.454003e-03 | 2.837 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.454003e-03 | 2.837 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.276631e-03 | 2.894 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.253011e-03 | 2.902 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.283861e-03 | 2.891 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.365035e-03 | 2.865 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.215022e-03 | 2.915 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.289598e-03 | 2.890 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.395349e-03 | 2.855 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.362704e-03 | 2.866 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.278457e-03 | 2.893 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.365035e-03 | 2.865 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.278457e-03 | 2.893 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.232438e-03 | 2.909 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.253011e-03 | 2.902 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.278457e-03 | 2.893 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.456305e-03 | 2.837 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.463211e-03 | 2.835 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.485739e-03 | 2.828 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.493100e-03 | 2.826 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.533995e-03 | 2.814 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.533995e-03 | 2.814 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.584746e-03 | 2.800 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 1.599528e-03 | 2.796 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.601697e-03 | 2.795 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.625027e-03 | 2.789 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.625027e-03 | 2.789 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.656554e-03 | 2.781 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.662578e-03 | 2.779 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.662578e-03 | 2.779 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.669252e-03 | 2.777 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.669252e-03 | 2.777 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.671029e-03 | 2.777 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.675960e-03 | 2.776 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.711258e-03 | 2.767 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.813459e-03 | 2.741 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.843306e-03 | 2.734 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.865275e-03 | 2.729 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 1.865275e-03 | 2.729 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.883593e-03 | 2.725 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.883593e-03 | 2.725 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.898030e-03 | 2.722 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.921024e-03 | 2.716 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.989543e-03 | 2.701 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.047104e-03 | 2.689 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.047104e-03 | 2.689 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.127957e-03 | 2.672 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.179626e-03 | 2.662 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 2.195704e-03 | 2.658 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.236673e-03 | 2.650 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.284657e-03 | 2.641 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.329658e-03 | 2.633 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.481054e-03 | 2.605 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.502242e-03 | 2.602 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.510497e-03 | 2.600 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.549959e-03 | 2.593 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.549959e-03 | 2.593 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.549959e-03 | 2.593 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.644079e-03 | 2.578 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.644079e-03 | 2.578 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.281117e-03 | 2.484 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.281117e-03 | 2.484 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.693906e-03 | 2.570 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.019253e-03 | 2.520 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.210793e-03 | 2.493 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.879629e-03 | 2.541 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.250749e-03 | 2.488 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.702860e-03 | 2.568 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.918958e-03 | 2.535 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 2.879629e-03 | 2.541 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.970054e-03 | 2.527 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.210793e-03 | 2.493 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.210793e-03 | 2.493 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.884084e-03 | 2.540 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.293418e-03 | 2.482 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.300595e-03 | 2.481 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.300595e-03 | 2.481 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.300595e-03 | 2.481 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.350634e-03 | 2.475 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.663186e-03 | 2.436 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.663186e-03 | 2.436 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.663186e-03 | 2.436 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.768510e-03 | 2.424 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.768510e-03 | 2.424 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.768510e-03 | 2.424 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.768510e-03 | 2.424 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.776225e-03 | 2.423 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.939106e-03 | 2.405 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.042256e-03 | 2.393 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.053446e-03 | 2.392 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.058111e-03 | 2.392 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.188754e-03 | 2.378 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.286841e-03 | 2.368 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.286841e-03 | 2.368 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.289578e-03 | 2.368 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 4.319571e-03 | 2.365 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.327591e-03 | 2.364 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.327591e-03 | 2.364 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.380360e-03 | 2.358 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.568249e-03 | 2.340 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.761536e-03 | 2.322 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.859148e-03 | 2.313 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.859148e-03 | 2.313 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.970925e-03 | 2.304 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.998093e-03 | 2.301 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.031615e-03 | 2.298 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 5.031615e-03 | 2.298 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.411288e-03 | 2.267 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.431182e-03 | 2.265 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 5.431182e-03 | 2.265 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.468904e-03 | 2.262 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.468904e-03 | 2.262 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.468904e-03 | 2.262 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.523038e-03 | 2.258 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 6.921019e-03 | 2.160 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 6.921019e-03 | 2.160 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 6.921019e-03 | 2.160 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 6.921019e-03 | 2.160 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 6.921019e-03 | 2.160 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.011375e-03 | 2.154 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.037776e-03 | 2.153 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.912545e-03 | 2.160 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.366762e-03 | 2.196 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 5.887396e-03 | 2.230 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.496452e-03 | 2.187 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.833721e-03 | 2.165 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.496452e-03 | 2.187 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.414150e-03 | 2.130 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 6.794659e-03 | 2.168 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 6.794659e-03 | 2.168 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 5.694892e-03 | 2.245 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 5.694892e-03 | 2.245 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.180317e-03 | 2.209 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.821297e-03 | 2.166 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.434914e-03 | 2.129 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 6.484151e-03 | 2.188 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 7.434914e-03 | 2.129 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.639200e-03 | 2.249 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.705590e-03 | 2.174 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.308590e-03 | 2.136 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.695135e-03 | 2.244 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 6.180317e-03 | 2.209 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.821297e-03 | 2.166 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.694892e-03 | 2.245 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 6.180317e-03 | 2.209 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.526707e-03 | 2.185 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.642661e-03 | 2.178 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.501476e-03 | 2.125 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.559479e-03 | 2.122 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 7.594120e-03 | 2.120 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.761915e-03 | 2.110 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 8.035541e-03 | 2.095 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.180006e-03 | 2.087 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.291572e-03 | 2.081 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.326896e-03 | 2.080 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.391659e-03 | 2.076 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 8.477895e-03 | 2.072 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.477895e-03 | 2.072 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.607505e-03 | 2.065 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 8.632167e-03 | 2.064 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.632167e-03 | 2.064 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.807373e-03 | 2.055 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 8.924213e-03 | 2.049 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 8.924213e-03 | 2.049 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.924213e-03 | 2.049 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 8.924213e-03 | 2.049 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 8.924213e-03 | 2.049 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.924213e-03 | 2.049 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.077857e-03 | 2.042 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.090855e-03 | 2.041 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.400979e-03 | 2.027 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 9.883208e-03 | 2.005 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 9.955922e-03 | 2.002 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.014208e-02 | 1.994 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.019604e-02 | 1.992 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.019604e-02 | 1.992 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.025255e-02 | 1.989 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.041043e-02 | 1.983 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.057980e-02 | 1.976 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.073363e-02 | 1.969 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.126151e-02 | 1.948 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 1.134087e-02 | 1.945 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.144750e-02 | 1.941 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.150434e-02 | 1.939 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.153381e-02 | 1.938 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.182943e-02 | 1.927 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.213813e-02 | 1.916 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.218432e-02 | 1.914 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.224966e-02 | 1.912 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.270054e-02 | 1.896 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.305736e-02 | 1.884 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.312961e-02 | 1.882 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.312961e-02 | 1.882 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.312961e-02 | 1.882 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.363853e-02 | 1.865 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 1.363853e-02 | 1.865 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.363853e-02 | 1.865 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.370368e-02 | 1.863 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.370368e-02 | 1.863 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.437745e-02 | 1.842 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.438847e-02 | 1.842 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.442699e-02 | 1.841 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.456680e-02 | 1.837 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.495782e-02 | 1.825 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.509905e-02 | 1.821 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.550316e-02 | 1.810 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.565212e-02 | 1.805 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.622733e-02 | 1.790 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.630933e-02 | 1.788 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.630933e-02 | 1.788 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.638540e-02 | 1.786 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.716070e-02 | 1.765 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 1.728176e-02 | 1.762 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.728176e-02 | 1.762 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.728176e-02 | 1.762 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.730927e-02 | 1.762 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.776765e-02 | 1.750 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.776765e-02 | 1.750 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.776765e-02 | 1.750 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.776765e-02 | 1.750 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.776765e-02 | 1.750 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.776765e-02 | 1.750 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.776765e-02 | 1.750 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.793974e-02 | 1.746 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.818119e-02 | 1.740 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 1.857176e-02 | 1.731 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.436794e-02 | 1.613 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.436794e-02 | 1.613 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.436794e-02 | 1.613 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.322591e-02 | 1.634 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.322591e-02 | 1.634 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.671769e-02 | 1.573 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.671769e-02 | 1.573 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.225699e-02 | 1.653 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.507265e-02 | 1.601 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.988995e-02 | 1.701 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.187553e-02 | 1.660 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.892847e-02 | 1.723 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.278654e-02 | 1.642 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.671966e-02 | 1.573 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.425041e-02 | 1.615 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.068884e-02 | 1.684 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.318914e-02 | 1.635 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.199677e-02 | 1.658 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.590541e-02 | 1.587 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.507265e-02 | 1.601 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 2.160209e-02 | 1.666 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.811620e-02 | 1.551 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.590541e-02 | 1.587 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.671966e-02 | 1.573 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.477319e-02 | 1.606 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 2.590541e-02 | 1.587 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.782291e-02 | 1.556 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.004344e-02 | 1.698 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.671769e-02 | 1.573 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.399714e-02 | 1.620 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.257339e-02 | 1.646 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.318914e-02 | 1.635 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.225699e-02 | 1.653 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.952247e-02 | 1.709 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.811620e-02 | 1.551 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.952247e-02 | 1.709 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.317886e-02 | 1.635 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.436794e-02 | 1.613 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.317886e-02 | 1.635 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.613335e-02 | 1.583 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.202250e-02 | 1.657 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.225699e-02 | 1.653 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.322591e-02 | 1.634 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.502302e-02 | 1.602 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.892847e-02 | 1.723 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.004344e-02 | 1.698 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.226608e-02 | 1.652 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.918886e-02 | 1.717 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.869936e-02 | 1.542 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.869936e-02 | 1.542 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.018618e-02 | 1.520 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.045523e-02 | 1.516 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.052708e-02 | 1.515 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.052708e-02 | 1.515 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.052708e-02 | 1.515 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.052708e-02 | 1.515 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.052708e-02 | 1.515 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.068783e-02 | 1.513 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.068783e-02 | 1.513 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.068783e-02 | 1.513 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.068783e-02 | 1.513 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 3.068783e-02 | 1.513 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.093008e-02 | 1.510 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.098891e-02 | 1.509 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.101173e-02 | 1.508 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.102818e-02 | 1.508 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.139373e-02 | 1.503 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.145041e-02 | 1.502 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.237782e-02 | 1.490 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.239057e-02 | 1.490 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.240673e-02 | 1.489 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.310546e-02 | 1.480 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.310546e-02 | 1.480 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.329468e-02 | 1.478 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.392420e-02 | 1.469 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.466104e-02 | 1.460 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.466104e-02 | 1.460 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.471432e-02 | 1.459 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 3.471432e-02 | 1.459 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.491070e-02 | 1.457 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.491070e-02 | 1.457 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.491070e-02 | 1.457 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.502445e-02 | 1.456 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.595624e-02 | 1.444 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.595624e-02 | 1.444 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 3.595624e-02 | 1.444 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 3.595624e-02 | 1.444 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.616892e-02 | 1.442 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.662848e-02 | 1.436 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.662848e-02 | 1.436 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.835953e-02 | 1.416 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.854325e-02 | 1.414 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.854325e-02 | 1.414 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.912514e-02 | 1.408 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.912514e-02 | 1.408 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.912514e-02 | 1.408 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.950827e-02 | 1.403 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.967883e-02 | 1.401 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.000301e-02 | 1.398 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.001316e-02 | 1.398 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.154249e-02 | 1.382 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 4.171439e-02 | 1.380 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.171439e-02 | 1.380 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 4.171439e-02 | 1.380 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.231838e-02 | 1.373 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.268133e-02 | 1.370 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 4.268133e-02 | 1.370 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.268133e-02 | 1.370 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.309512e-02 | 1.366 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.357402e-02 | 1.361 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.357402e-02 | 1.361 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 4.438398e-02 | 1.353 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.452499e-02 | 1.351 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.632304e-02 | 1.334 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.632304e-02 | 1.334 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.687568e-02 | 1.329 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.687568e-02 | 1.329 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.689520e-02 | 1.329 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.694244e-02 | 1.328 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.694244e-02 | 1.328 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.702943e-02 | 1.328 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.796298e-02 | 1.319 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 4.796298e-02 | 1.319 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.796298e-02 | 1.319 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.797561e-02 | 1.319 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.903315e-02 | 1.310 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.905945e-02 | 1.309 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.905945e-02 | 1.309 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.905945e-02 | 1.309 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.985132e-02 | 1.302 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.131660e-02 | 1.290 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.145784e-02 | 1.289 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 5.214397e-02 | 1.283 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.309196e-02 | 1.275 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.309196e-02 | 1.275 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.309196e-02 | 1.275 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.309196e-02 | 1.275 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.309196e-02 | 1.275 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.411947e-02 | 1.267 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.412800e-02 | 1.267 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.427889e-02 | 1.265 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.453411e-02 | 1.263 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.453411e-02 | 1.263 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.469988e-02 | 1.262 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.469988e-02 | 1.262 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 5.469988e-02 | 1.262 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.469988e-02 | 1.262 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.492295e-02 | 1.260 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.605886e-02 | 1.251 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.605886e-02 | 1.251 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.622947e-02 | 1.250 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.734949e-02 | 1.241 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 5.945410e-02 | 1.226 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 6.034792e-02 | 1.219 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 6.034792e-02 | 1.219 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.076149e-02 | 1.216 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.125855e-02 | 1.213 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.192029e-02 | 1.208 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.192029e-02 | 1.208 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.192029e-02 | 1.208 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 6.600311e-02 | 1.180 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.649989e-02 | 1.177 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.649989e-02 | 1.177 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.649989e-02 | 1.177 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 6.654556e-02 | 1.177 | 0 | 0 |
| Translation | R-HSA-72766 | 6.750090e-02 | 1.171 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 6.947188e-02 | 1.158 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.947188e-02 | 1.158 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 6.947188e-02 | 1.158 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.961693e-02 | 1.157 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.961693e-02 | 1.157 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.961693e-02 | 1.157 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.961693e-02 | 1.157 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.209033e-02 | 1.142 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.298782e-02 | 1.137 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.298782e-02 | 1.137 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.298782e-02 | 1.137 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.669205e-02 | 1.115 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.669205e-02 | 1.115 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.669205e-02 | 1.115 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 7.669205e-02 | 1.115 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 7.669205e-02 | 1.115 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.778027e-02 | 1.109 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.778027e-02 | 1.109 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 7.789196e-02 | 1.109 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 7.906541e-02 | 1.102 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.980834e-02 | 1.098 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.980834e-02 | 1.098 | 0 | 0 |
| t(4;14) translocations of FGFR3 | R-HSA-2033515 | 1.679776e-01 | 0.775 | 0 | 0 |
| Signaling by FGFR3 fusions in cancer | R-HSA-8853334 | 1.679776e-01 | 0.775 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 1.679776e-01 | 0.775 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 1.679776e-01 | 0.775 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.679776e-01 | 0.775 | 0 | 0 |
| Defective HK1 causes hexokinase deficiency (HK deficiency) | R-HSA-5619056 | 1.679776e-01 | 0.775 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 1.679776e-01 | 0.775 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 1.679776e-01 | 0.775 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 8.725174e-02 | 1.059 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 1.062075e-01 | 0.974 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.062075e-01 | 0.974 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.261370e-01 | 0.899 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.468575e-01 | 0.833 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 1.468575e-01 | 0.833 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.468575e-01 | 0.833 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 8.808599e-02 | 1.055 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 8.808599e-02 | 1.055 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.808599e-02 | 1.055 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 8.808599e-02 | 1.055 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.808599e-02 | 1.055 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.808599e-02 | 1.055 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.001424e-01 | 0.999 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 1.001424e-01 | 0.999 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.128165e-01 | 0.948 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.639870e-02 | 1.063 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.049453e-01 | 0.979 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.468066e-01 | 0.833 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.187078e-01 | 0.926 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.254845e-01 | 0.901 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.551041e-01 | 0.809 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.648522e-01 | 0.783 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.444374e-02 | 1.073 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.291848e-01 | 0.889 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.284563e-01 | 0.891 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 1.187078e-01 | 0.926 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.567160e-01 | 0.805 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 1.260622e-01 | 0.899 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 1.260622e-01 | 0.899 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 9.442824e-02 | 1.025 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 9.442824e-02 | 1.025 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 8.725174e-02 | 1.059 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.808599e-02 | 1.055 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.128165e-01 | 0.948 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 1.540801e-01 | 0.812 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 1.251303e-01 | 0.903 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.001424e-01 | 0.999 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.695699e-02 | 1.061 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.444500e-02 | 1.073 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 8.725174e-02 | 1.059 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.398325e-01 | 0.854 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.125431e-01 | 0.949 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 1.107683e-01 | 0.956 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.412021e-01 | 0.850 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.216441e-01 | 0.915 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 1.251303e-01 | 0.903 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.164692e-01 | 0.934 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.468575e-01 | 0.833 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.064418e-01 | 0.973 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.354559e-01 | 0.868 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.179637e-01 | 0.928 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.273954e-01 | 0.895 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.180418e-02 | 1.037 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.153768e-01 | 0.938 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.153768e-01 | 0.938 | 0 | 0 |
| Proton/oligopeptide cotransporters | R-HSA-427975 | 8.725174e-02 | 1.059 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 1.261370e-01 | 0.899 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.468575e-01 | 0.833 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 1.468575e-01 | 0.833 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.148418e-01 | 0.940 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.551041e-01 | 0.809 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 1.198961e-01 | 0.921 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 1.198961e-01 | 0.921 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.382819e-01 | 0.859 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.575358e-01 | 0.803 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 1.062075e-01 | 0.974 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.639870e-02 | 1.063 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.652407e-01 | 0.782 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 1.581539e-01 | 0.801 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.354559e-01 | 0.868 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.520740e-02 | 1.021 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.254845e-01 | 0.901 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.261370e-01 | 0.899 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 9.442824e-02 | 1.025 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.284563e-01 | 0.891 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.023666e-01 | 0.990 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 9.347568e-02 | 1.029 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.423767e-01 | 0.847 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 8.444374e-02 | 1.073 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.679776e-01 | 0.775 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 8.725174e-02 | 1.059 | 0 | 0 |
| SLC-mediated transport of oligopeptides | R-HSA-9959399 | 1.261370e-01 | 0.899 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.128165e-01 | 0.948 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.695699e-02 | 1.061 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 9.442824e-02 | 1.025 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.436294e-01 | 0.843 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 1.103115e-01 | 0.957 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.106759e-01 | 0.956 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.251303e-01 | 0.903 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.633730e-02 | 1.016 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.106759e-01 | 0.956 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.011811e-01 | 0.995 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 8.808599e-02 | 1.055 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.168936e-01 | 0.932 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.475397e-01 | 0.831 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.273954e-01 | 0.895 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.468575e-01 | 0.833 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.128165e-01 | 0.948 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.128165e-01 | 0.948 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.060067e-01 | 0.975 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.264688e-01 | 0.898 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.001424e-01 | 0.999 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 8.725174e-02 | 1.059 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.639870e-02 | 1.063 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.357918e-01 | 0.867 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 1.468066e-01 | 0.833 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.468575e-01 | 0.833 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.001424e-01 | 0.999 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.248243e-01 | 0.904 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.179637e-01 | 0.928 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.428162e-01 | 0.845 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 1.117466e-01 | 0.952 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.357918e-01 | 0.867 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 1.551041e-01 | 0.809 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.668704e-02 | 1.062 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.528253e-01 | 0.816 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.682048e-01 | 0.774 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.682048e-01 | 0.774 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 1.682048e-01 | 0.774 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.682048e-01 | 0.774 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.682048e-01 | 0.774 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.682048e-01 | 0.774 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.682048e-01 | 0.774 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.682048e-01 | 0.774 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 1.682048e-01 | 0.774 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.682586e-01 | 0.774 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.687579e-01 | 0.773 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.698126e-01 | 0.770 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.738783e-01 | 0.760 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.748365e-01 | 0.757 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.748365e-01 | 0.757 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.817610e-01 | 0.740 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.817610e-01 | 0.740 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.817610e-01 | 0.740 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.838189e-01 | 0.736 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.838189e-01 | 0.736 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.838189e-01 | 0.736 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.841252e-01 | 0.735 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.862341e-01 | 0.730 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.862341e-01 | 0.730 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.888952e-01 | 0.724 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.900314e-01 | 0.721 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.900314e-01 | 0.721 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 1.900314e-01 | 0.721 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.900314e-01 | 0.721 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.900314e-01 | 0.721 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.900314e-01 | 0.721 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.973229e-01 | 0.705 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.979392e-01 | 0.703 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.030891e-01 | 0.692 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.060814e-01 | 0.686 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.064387e-01 | 0.685 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.120598e-01 | 0.674 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.120598e-01 | 0.674 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 2.122051e-01 | 0.673 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 2.122051e-01 | 0.673 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 2.122051e-01 | 0.673 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 2.122051e-01 | 0.673 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 2.122051e-01 | 0.673 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 2.122051e-01 | 0.673 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 2.149082e-01 | 0.668 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.149082e-01 | 0.668 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.149082e-01 | 0.668 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 2.168836e-01 | 0.664 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.168836e-01 | 0.664 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 2.168836e-01 | 0.664 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.174537e-01 | 0.663 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.174537e-01 | 0.663 | 0 | 0 |
| Defective ALG9 causes CDG-1l | R-HSA-4720454 | 2.174537e-01 | 0.663 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.174537e-01 | 0.663 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.174537e-01 | 0.663 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.174537e-01 | 0.663 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.174537e-01 | 0.663 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.174537e-01 | 0.663 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 2.174537e-01 | 0.663 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.174537e-01 | 0.663 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.174537e-01 | 0.663 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 2.174537e-01 | 0.663 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 2.174537e-01 | 0.663 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.174537e-01 | 0.663 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 2.174537e-01 | 0.663 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 2.174537e-01 | 0.663 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.174537e-01 | 0.663 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 2.174537e-01 | 0.663 | 0 | 0 |
| The AIM2 inflammasome | R-HSA-844615 | 2.174537e-01 | 0.663 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.174537e-01 | 0.663 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 2.174537e-01 | 0.663 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 2.174537e-01 | 0.663 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.191237e-01 | 0.659 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.191237e-01 | 0.659 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.191237e-01 | 0.659 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.191237e-01 | 0.659 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.191237e-01 | 0.659 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.222653e-01 | 0.653 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.243474e-01 | 0.649 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.278572e-01 | 0.642 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 2.298020e-01 | 0.639 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.308479e-01 | 0.637 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 2.314498e-01 | 0.636 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.320099e-01 | 0.634 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.320099e-01 | 0.634 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.346074e-01 | 0.630 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.346074e-01 | 0.630 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 2.346074e-01 | 0.630 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.346074e-01 | 0.630 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 2.354702e-01 | 0.628 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.389888e-01 | 0.622 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 2.389888e-01 | 0.622 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 2.389888e-01 | 0.622 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.407529e-01 | 0.618 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.413477e-01 | 0.617 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.413477e-01 | 0.617 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.413477e-01 | 0.617 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.413477e-01 | 0.617 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.413477e-01 | 0.617 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.449479e-01 | 0.611 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.449479e-01 | 0.611 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.449479e-01 | 0.611 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.450753e-01 | 0.611 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 2.450753e-01 | 0.611 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.450753e-01 | 0.611 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.450753e-01 | 0.611 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 2.552488e-01 | 0.593 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 2.571331e-01 | 0.590 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.571331e-01 | 0.590 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.571331e-01 | 0.590 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.571331e-01 | 0.590 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.571331e-01 | 0.590 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.571331e-01 | 0.590 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.571331e-01 | 0.590 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 2.571331e-01 | 0.590 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 2.571331e-01 | 0.590 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.571331e-01 | 0.590 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 2.571331e-01 | 0.590 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 2.571331e-01 | 0.590 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.582980e-01 | 0.588 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.616716e-01 | 0.582 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.616716e-01 | 0.582 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.616716e-01 | 0.582 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 2.639905e-01 | 0.578 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 2.639905e-01 | 0.578 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 2.639905e-01 | 0.578 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.639905e-01 | 0.578 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 2.639905e-01 | 0.578 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 2.639905e-01 | 0.578 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 2.639905e-01 | 0.578 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 2.639905e-01 | 0.578 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 2.639905e-01 | 0.578 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.650330e-01 | 0.577 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 2.687893e-01 | 0.571 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.716568e-01 | 0.566 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.716568e-01 | 0.566 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.716568e-01 | 0.566 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.716568e-01 | 0.566 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 2.731958e-01 | 0.564 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.768292e-01 | 0.558 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 2.796883e-01 | 0.553 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.796883e-01 | 0.553 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 2.796883e-01 | 0.553 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.797460e-01 | 0.553 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 2.797460e-01 | 0.553 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.797460e-01 | 0.553 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 2.820764e-01 | 0.550 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.888660e-01 | 0.539 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.893195e-01 | 0.539 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 2.910241e-01 | 0.536 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 2.946156e-01 | 0.531 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.962754e-01 | 0.528 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.986984e-01 | 0.525 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.986984e-01 | 0.525 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.021900e-01 | 0.520 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.021900e-01 | 0.520 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 3.021900e-01 | 0.520 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 3.066827e-01 | 0.513 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 3.077624e-01 | 0.512 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 3.077624e-01 | 0.512 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 3.077624e-01 | 0.512 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 3.077624e-01 | 0.512 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.077624e-01 | 0.512 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 3.077624e-01 | 0.512 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 3.077624e-01 | 0.512 | 0 | 0 |
| Interleukin-38 signaling | R-HSA-9007892 | 3.077624e-01 | 0.512 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.123405e-01 | 0.505 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.123405e-01 | 0.505 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 3.128594e-01 | 0.505 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.128594e-01 | 0.505 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.128594e-01 | 0.505 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.175794e-01 | 0.498 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.179178e-01 | 0.498 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.201998e-01 | 0.495 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.241758e-01 | 0.489 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.245649e-01 | 0.489 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 3.245649e-01 | 0.489 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.245649e-01 | 0.489 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 3.245649e-01 | 0.489 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.245649e-01 | 0.489 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.260374e-01 | 0.487 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 3.278780e-01 | 0.484 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.294647e-01 | 0.482 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.348454e-01 | 0.475 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.397701e-01 | 0.469 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.460598e-01 | 0.461 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.460598e-01 | 0.461 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 3.467485e-01 | 0.460 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.467485e-01 | 0.460 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.467485e-01 | 0.460 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 3.467485e-01 | 0.460 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.467485e-01 | 0.460 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.489337e-01 | 0.457 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 3.489337e-01 | 0.457 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 3.489337e-01 | 0.457 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 3.489337e-01 | 0.457 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 3.489337e-01 | 0.457 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 3.489337e-01 | 0.457 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 3.489337e-01 | 0.457 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 3.489337e-01 | 0.457 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 3.489337e-01 | 0.457 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.489337e-01 | 0.457 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 3.535204e-01 | 0.452 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 3.535204e-01 | 0.452 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.560439e-01 | 0.448 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.560439e-01 | 0.448 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.626150e-01 | 0.441 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.670579e-01 | 0.435 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 3.670579e-01 | 0.435 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 3.672706e-01 | 0.435 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 3.672706e-01 | 0.435 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 3.680385e-01 | 0.434 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.686846e-01 | 0.433 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 3.686846e-01 | 0.433 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 3.686846e-01 | 0.433 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 3.686846e-01 | 0.433 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.686846e-01 | 0.433 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.686851e-01 | 0.433 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 3.750352e-01 | 0.426 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 3.772398e-01 | 0.423 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.791027e-01 | 0.421 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.791027e-01 | 0.421 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.791027e-01 | 0.421 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.800368e-01 | 0.420 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.810039e-01 | 0.419 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 3.876586e-01 | 0.412 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.876586e-01 | 0.412 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.876586e-01 | 0.412 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.876586e-01 | 0.412 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 3.876586e-01 | 0.412 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 3.876586e-01 | 0.412 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 3.876586e-01 | 0.412 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.876586e-01 | 0.412 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 3.876586e-01 | 0.412 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.876586e-01 | 0.412 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 3.876586e-01 | 0.412 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 3.876586e-01 | 0.412 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.876586e-01 | 0.412 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 3.876586e-01 | 0.412 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.876586e-01 | 0.412 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.876586e-01 | 0.412 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.879129e-01 | 0.411 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.903242e-01 | 0.409 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 3.903242e-01 | 0.409 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 3.920277e-01 | 0.407 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.926909e-01 | 0.406 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.954970e-01 | 0.403 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.954970e-01 | 0.403 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.991941e-01 | 0.399 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.040001e-01 | 0.394 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 4.040001e-01 | 0.394 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.083559e-01 | 0.389 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.101637e-01 | 0.387 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.116251e-01 | 0.385 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.116251e-01 | 0.385 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.116251e-01 | 0.385 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 4.116251e-01 | 0.385 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 4.116251e-01 | 0.385 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 4.116251e-01 | 0.385 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.145193e-01 | 0.382 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.177274e-01 | 0.379 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.177274e-01 | 0.379 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.219445e-01 | 0.375 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.219445e-01 | 0.375 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.219445e-01 | 0.375 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 4.240823e-01 | 0.373 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 4.240823e-01 | 0.373 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 4.240823e-01 | 0.373 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 4.240823e-01 | 0.373 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 4.240823e-01 | 0.373 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 4.240823e-01 | 0.373 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 4.240823e-01 | 0.373 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 4.240823e-01 | 0.373 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 4.240823e-01 | 0.373 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 4.240823e-01 | 0.373 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 4.240823e-01 | 0.373 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 4.240823e-01 | 0.373 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.240823e-01 | 0.373 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 4.278483e-01 | 0.369 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.278483e-01 | 0.369 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.278483e-01 | 0.369 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.279112e-01 | 0.369 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.279112e-01 | 0.369 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.279112e-01 | 0.369 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.316376e-01 | 0.365 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 4.325509e-01 | 0.364 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.325509e-01 | 0.364 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 4.325509e-01 | 0.364 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 4.325509e-01 | 0.364 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.438885e-01 | 0.353 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.438885e-01 | 0.353 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.488771e-01 | 0.348 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 4.530710e-01 | 0.344 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.530710e-01 | 0.344 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 4.530710e-01 | 0.344 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.530710e-01 | 0.344 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.538109e-01 | 0.343 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 4.583416e-01 | 0.339 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.583416e-01 | 0.339 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 4.583416e-01 | 0.339 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 4.583416e-01 | 0.339 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.583416e-01 | 0.339 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.583416e-01 | 0.339 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 4.583416e-01 | 0.339 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 4.583416e-01 | 0.339 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.583416e-01 | 0.339 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 4.583416e-01 | 0.339 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.583416e-01 | 0.339 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.583416e-01 | 0.339 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.596871e-01 | 0.338 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 4.596871e-01 | 0.338 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.596871e-01 | 0.338 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.629438e-01 | 0.334 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 4.731597e-01 | 0.325 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.731597e-01 | 0.325 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.752897e-01 | 0.323 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.752897e-01 | 0.323 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.753997e-01 | 0.323 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.753997e-01 | 0.323 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.865352e-01 | 0.313 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.871397e-01 | 0.312 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.903424e-01 | 0.310 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.905648e-01 | 0.309 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 4.905648e-01 | 0.309 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.905648e-01 | 0.309 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.905648e-01 | 0.309 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 4.905648e-01 | 0.309 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 4.905648e-01 | 0.309 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.905648e-01 | 0.309 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.905648e-01 | 0.309 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.905648e-01 | 0.309 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.905648e-01 | 0.309 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.905648e-01 | 0.309 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 4.927956e-01 | 0.307 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.927956e-01 | 0.307 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.927956e-01 | 0.307 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 4.927956e-01 | 0.307 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 4.927956e-01 | 0.307 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.945012e-01 | 0.306 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.945012e-01 | 0.306 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.945012e-01 | 0.306 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.979389e-01 | 0.303 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 5.053960e-01 | 0.296 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.058468e-01 | 0.296 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 5.119616e-01 | 0.291 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 5.119616e-01 | 0.291 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 5.119616e-01 | 0.291 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.119616e-01 | 0.291 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 5.119616e-01 | 0.291 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 5.119616e-01 | 0.291 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 5.119616e-01 | 0.291 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 5.119616e-01 | 0.291 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.142197e-01 | 0.289 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.142197e-01 | 0.289 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 5.207747e-01 | 0.283 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 5.208729e-01 | 0.283 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 5.208729e-01 | 0.283 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 5.208729e-01 | 0.283 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 5.208729e-01 | 0.283 | 0 | 0 |
| Enzymatic degradation of Dopamine by monoamine oxidase | R-HSA-379398 | 5.208729e-01 | 0.283 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 5.208729e-01 | 0.283 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 5.208729e-01 | 0.283 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 5.208729e-01 | 0.283 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 5.208729e-01 | 0.283 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 5.208729e-01 | 0.283 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 5.208729e-01 | 0.283 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 5.208729e-01 | 0.283 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.208729e-01 | 0.283 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 5.208729e-01 | 0.283 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 5.208729e-01 | 0.283 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.208729e-01 | 0.283 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.299670e-01 | 0.276 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.306441e-01 | 0.275 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.306441e-01 | 0.275 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 5.306441e-01 | 0.275 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.317592e-01 | 0.274 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.354535e-01 | 0.271 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 5.354535e-01 | 0.271 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.397117e-01 | 0.268 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 5.488328e-01 | 0.261 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 5.488328e-01 | 0.261 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 5.488328e-01 | 0.261 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.493795e-01 | 0.260 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.493795e-01 | 0.260 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.493795e-01 | 0.260 | 0 | 0 |
| Enzymatic degradation of dopamine by COMT | R-HSA-379397 | 5.493795e-01 | 0.260 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 5.493795e-01 | 0.260 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 5.493795e-01 | 0.260 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 5.493795e-01 | 0.260 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 5.493795e-01 | 0.260 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.493795e-01 | 0.260 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.493795e-01 | 0.260 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.498733e-01 | 0.260 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.498733e-01 | 0.260 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.517167e-01 | 0.258 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.537257e-01 | 0.257 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 5.537257e-01 | 0.257 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.602412e-01 | 0.252 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.640256e-01 | 0.249 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 5.665204e-01 | 0.247 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 5.665204e-01 | 0.247 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 5.665204e-01 | 0.247 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.665204e-01 | 0.247 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 5.665204e-01 | 0.247 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.665204e-01 | 0.247 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.665204e-01 | 0.247 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 5.665204e-01 | 0.247 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.665204e-01 | 0.247 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.671326e-01 | 0.246 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 5.701387e-01 | 0.244 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 5.757506e-01 | 0.240 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.761918e-01 | 0.239 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.761918e-01 | 0.239 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.761918e-01 | 0.239 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.761918e-01 | 0.239 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 5.761918e-01 | 0.239 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.761918e-01 | 0.239 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 5.761918e-01 | 0.239 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.837020e-01 | 0.234 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 5.837020e-01 | 0.234 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 5.914991e-01 | 0.228 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.944943e-01 | 0.226 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 5.944943e-01 | 0.226 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 5.990910e-01 | 0.223 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.003753e-01 | 0.222 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.003753e-01 | 0.222 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 6.003753e-01 | 0.222 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 6.003753e-01 | 0.222 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.003753e-01 | 0.222 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 6.003753e-01 | 0.222 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 6.003753e-01 | 0.222 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 6.014102e-01 | 0.221 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 6.014102e-01 | 0.221 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 6.014102e-01 | 0.221 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.014102e-01 | 0.221 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 6.014102e-01 | 0.221 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 6.014102e-01 | 0.221 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 6.014102e-01 | 0.221 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 6.014102e-01 | 0.221 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.014102e-01 | 0.221 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 6.014102e-01 | 0.221 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 6.014102e-01 | 0.221 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 6.014102e-01 | 0.221 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.014102e-01 | 0.221 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.017571e-01 | 0.221 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 6.029815e-01 | 0.220 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 6.104677e-01 | 0.214 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.163792e-01 | 0.210 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.165398e-01 | 0.210 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.165398e-01 | 0.210 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 6.165398e-01 | 0.210 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 6.165398e-01 | 0.210 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 6.178279e-01 | 0.209 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 6.216434e-01 | 0.206 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 6.227566e-01 | 0.206 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.251294e-01 | 0.204 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 6.251294e-01 | 0.204 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.251294e-01 | 0.204 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 6.251294e-01 | 0.204 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.251294e-01 | 0.204 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 6.251294e-01 | 0.204 | 0 | 0 |
| Synthesis of GDP-mannose | R-HSA-446205 | 6.251294e-01 | 0.204 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 6.251294e-01 | 0.204 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 6.251294e-01 | 0.204 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.251294e-01 | 0.204 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.251294e-01 | 0.204 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.251294e-01 | 0.204 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 6.251294e-01 | 0.204 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.251294e-01 | 0.204 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 6.305529e-01 | 0.200 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 6.321972e-01 | 0.199 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.321972e-01 | 0.199 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.321972e-01 | 0.199 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 6.326147e-01 | 0.199 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.429816e-01 | 0.192 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.433789e-01 | 0.192 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 6.473505e-01 | 0.189 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 6.473505e-01 | 0.189 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.473505e-01 | 0.189 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.473505e-01 | 0.189 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 6.474385e-01 | 0.189 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.474385e-01 | 0.189 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 6.474385e-01 | 0.189 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 6.474385e-01 | 0.189 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.474385e-01 | 0.189 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 6.474385e-01 | 0.189 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 6.474385e-01 | 0.189 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 6.496261e-01 | 0.187 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 6.592429e-01 | 0.181 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 6.620043e-01 | 0.179 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 6.620043e-01 | 0.179 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.659848e-01 | 0.177 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.669439e-01 | 0.176 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.680807e-01 | 0.175 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.684212e-01 | 0.175 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.684212e-01 | 0.175 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 6.684212e-01 | 0.175 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.684212e-01 | 0.175 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.684212e-01 | 0.175 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 6.684212e-01 | 0.175 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 6.684212e-01 | 0.175 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 6.684212e-01 | 0.175 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 6.684212e-01 | 0.175 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 6.684212e-01 | 0.175 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 6.684212e-01 | 0.175 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 6.684212e-01 | 0.175 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 6.761642e-01 | 0.170 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.761642e-01 | 0.170 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.761642e-01 | 0.170 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 6.783575e-01 | 0.169 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.825028e-01 | 0.166 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 6.881563e-01 | 0.162 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.881563e-01 | 0.162 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.881563e-01 | 0.162 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.881563e-01 | 0.162 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.881563e-01 | 0.162 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 6.881563e-01 | 0.162 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 6.881563e-01 | 0.162 | 0 | 0 |
| Synthesis of 12-eicosatetraenoic acid derivatives | R-HSA-2142712 | 6.881563e-01 | 0.162 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 6.881563e-01 | 0.162 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.881563e-01 | 0.162 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.881563e-01 | 0.162 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 6.881563e-01 | 0.162 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.898373e-01 | 0.161 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 6.898373e-01 | 0.161 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.912934e-01 | 0.160 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.006471e-01 | 0.155 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.006471e-01 | 0.155 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.030312e-01 | 0.153 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 7.030312e-01 | 0.153 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.030312e-01 | 0.153 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.030312e-01 | 0.153 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 7.067179e-01 | 0.151 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 7.067179e-01 | 0.151 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 7.067179e-01 | 0.151 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 7.067179e-01 | 0.151 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.067179e-01 | 0.151 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 7.067179e-01 | 0.151 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 7.067179e-01 | 0.151 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.067179e-01 | 0.151 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.067179e-01 | 0.151 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.067179e-01 | 0.151 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 7.067179e-01 | 0.151 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 7.112877e-01 | 0.148 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.127883e-01 | 0.147 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 7.127883e-01 | 0.147 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.157545e-01 | 0.145 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.157545e-01 | 0.145 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 7.157545e-01 | 0.145 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.157545e-01 | 0.145 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.157545e-01 | 0.145 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.157545e-01 | 0.145 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 7.200847e-01 | 0.143 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.216345e-01 | 0.142 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.218473e-01 | 0.142 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.218473e-01 | 0.142 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 7.241758e-01 | 0.140 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 7.241758e-01 | 0.140 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 7.241758e-01 | 0.140 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 7.241758e-01 | 0.140 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 7.241758e-01 | 0.140 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.241758e-01 | 0.140 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 7.241758e-01 | 0.140 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 7.241758e-01 | 0.140 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 7.241758e-01 | 0.140 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 7.241758e-01 | 0.140 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.241758e-01 | 0.140 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 7.280166e-01 | 0.138 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.398271e-01 | 0.131 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 7.405082e-01 | 0.130 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.405954e-01 | 0.130 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 7.405954e-01 | 0.130 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.405954e-01 | 0.130 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.405954e-01 | 0.130 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.405954e-01 | 0.130 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.405954e-01 | 0.130 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.405954e-01 | 0.130 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.405954e-01 | 0.130 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 7.405954e-01 | 0.130 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.405954e-01 | 0.130 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.414574e-01 | 0.130 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 7.511964e-01 | 0.124 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 7.560385e-01 | 0.121 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.560385e-01 | 0.121 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.560385e-01 | 0.121 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.560385e-01 | 0.121 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.560385e-01 | 0.121 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.560385e-01 | 0.121 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.621352e-01 | 0.118 | 0 | 0 |
| Depurination | R-HSA-73927 | 7.621352e-01 | 0.118 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 7.621352e-01 | 0.118 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 7.621352e-01 | 0.118 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 7.628515e-01 | 0.118 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 7.705632e-01 | 0.113 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.705632e-01 | 0.113 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.705632e-01 | 0.113 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 7.705632e-01 | 0.113 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 7.705632e-01 | 0.113 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 7.705632e-01 | 0.113 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.705632e-01 | 0.113 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.705632e-01 | 0.113 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.717623e-01 | 0.113 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 7.726544e-01 | 0.112 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 7.726544e-01 | 0.112 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 7.777168e-01 | 0.109 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 7.777168e-01 | 0.109 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.777168e-01 | 0.109 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.827652e-01 | 0.106 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.827652e-01 | 0.106 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.827652e-01 | 0.106 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.837111e-01 | 0.106 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 7.842239e-01 | 0.106 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.842239e-01 | 0.106 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.842239e-01 | 0.106 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 7.842239e-01 | 0.106 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.842239e-01 | 0.106 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 7.842239e-01 | 0.106 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 7.842239e-01 | 0.106 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.860998e-01 | 0.105 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.867496e-01 | 0.104 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.867496e-01 | 0.104 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.939434e-01 | 0.100 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.970720e-01 | 0.099 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 7.970720e-01 | 0.099 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.970720e-01 | 0.099 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 7.970720e-01 | 0.099 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.970720e-01 | 0.099 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 8.011831e-01 | 0.096 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.018067e-01 | 0.096 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.018067e-01 | 0.096 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.020799e-01 | 0.096 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 8.020799e-01 | 0.096 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.077449e-01 | 0.093 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.091558e-01 | 0.092 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.103717e-01 | 0.091 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.107605e-01 | 0.091 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.107605e-01 | 0.091 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.107605e-01 | 0.091 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.205208e-01 | 0.086 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.205208e-01 | 0.086 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 8.205208e-01 | 0.086 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.205208e-01 | 0.086 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 8.205208e-01 | 0.086 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.207838e-01 | 0.086 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.211285e-01 | 0.086 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.275911e-01 | 0.082 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.307880e-01 | 0.081 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.307880e-01 | 0.081 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.312096e-01 | 0.080 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.312096e-01 | 0.080 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 8.312096e-01 | 0.080 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.312096e-01 | 0.080 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.312096e-01 | 0.080 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.312096e-01 | 0.080 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 8.312096e-01 | 0.080 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 8.312096e-01 | 0.080 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.312096e-01 | 0.080 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.330846e-01 | 0.079 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.354909e-01 | 0.078 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.354909e-01 | 0.078 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.354909e-01 | 0.078 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.412624e-01 | 0.075 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.412624e-01 | 0.075 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.430619e-01 | 0.074 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.503153e-01 | 0.070 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.507171e-01 | 0.070 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.507171e-01 | 0.070 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 8.507171e-01 | 0.070 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 8.531463e-01 | 0.069 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.562814e-01 | 0.067 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.572621e-01 | 0.067 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 8.582452e-01 | 0.066 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.596092e-01 | 0.066 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 8.596092e-01 | 0.066 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.596092e-01 | 0.066 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.596092e-01 | 0.066 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.596092e-01 | 0.066 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.596092e-01 | 0.066 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.607797e-01 | 0.065 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 8.622797e-01 | 0.064 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.679721e-01 | 0.061 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.679721e-01 | 0.061 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.679721e-01 | 0.061 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.679721e-01 | 0.061 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.679721e-01 | 0.061 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 8.679721e-01 | 0.061 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.702787e-01 | 0.060 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 8.729877e-01 | 0.059 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 8.741478e-01 | 0.058 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.754375e-01 | 0.058 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.758373e-01 | 0.058 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.758373e-01 | 0.058 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.758373e-01 | 0.058 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.758373e-01 | 0.058 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.758373e-01 | 0.058 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.821954e-01 | 0.054 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 8.821954e-01 | 0.054 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.821954e-01 | 0.054 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.822773e-01 | 0.054 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.832344e-01 | 0.054 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.832344e-01 | 0.054 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.860280e-01 | 0.053 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 8.864119e-01 | 0.052 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 8.877665e-01 | 0.052 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.879518e-01 | 0.052 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.889224e-01 | 0.051 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.901913e-01 | 0.051 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.901913e-01 | 0.051 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.930925e-01 | 0.049 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.952210e-01 | 0.048 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.954260e-01 | 0.048 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 8.958451e-01 | 0.048 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 8.967341e-01 | 0.047 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.970322e-01 | 0.047 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.013195e-01 | 0.045 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.017253e-01 | 0.045 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.065527e-01 | 0.043 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.086743e-01 | 0.042 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 9.086743e-01 | 0.042 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.106096e-01 | 0.041 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.141168e-01 | 0.039 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.141168e-01 | 0.039 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.141168e-01 | 0.039 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.141168e-01 | 0.039 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.161313e-01 | 0.038 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.163656e-01 | 0.038 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.192352e-01 | 0.037 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.192352e-01 | 0.037 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.204094e-01 | 0.036 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.240489e-01 | 0.034 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.279510e-01 | 0.032 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.285760e-01 | 0.032 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.302880e-01 | 0.031 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.314638e-01 | 0.031 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.325353e-01 | 0.030 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.328335e-01 | 0.030 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.328335e-01 | 0.030 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.328335e-01 | 0.030 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.328335e-01 | 0.030 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.328335e-01 | 0.030 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.353696e-01 | 0.029 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.368374e-01 | 0.028 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 9.406029e-01 | 0.027 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.406029e-01 | 0.027 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 9.406029e-01 | 0.027 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.439576e-01 | 0.025 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.439576e-01 | 0.025 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 9.441441e-01 | 0.025 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 9.441441e-01 | 0.025 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 9.441441e-01 | 0.025 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.441441e-01 | 0.025 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.441441e-01 | 0.025 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.441441e-01 | 0.025 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.441441e-01 | 0.025 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.441441e-01 | 0.025 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.441441e-01 | 0.025 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.441441e-01 | 0.025 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.474744e-01 | 0.023 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.474744e-01 | 0.023 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.474744e-01 | 0.023 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.474744e-01 | 0.023 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.474811e-01 | 0.023 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.476178e-01 | 0.023 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.506063e-01 | 0.022 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.506063e-01 | 0.022 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.506063e-01 | 0.022 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.506063e-01 | 0.022 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.506063e-01 | 0.022 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.511293e-01 | 0.022 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.535516e-01 | 0.021 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.542646e-01 | 0.020 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.563215e-01 | 0.019 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.572173e-01 | 0.019 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.589264e-01 | 0.018 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.592416e-01 | 0.018 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 9.607779e-01 | 0.017 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.613761e-01 | 0.017 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.613761e-01 | 0.017 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.627440e-01 | 0.016 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.658462e-01 | 0.015 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.674914e-01 | 0.014 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.678835e-01 | 0.014 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.680904e-01 | 0.014 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.695128e-01 | 0.013 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.697024e-01 | 0.013 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.697994e-01 | 0.013 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.697994e-01 | 0.013 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.732955e-01 | 0.012 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.732955e-01 | 0.012 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.742965e-01 | 0.011 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.763872e-01 | 0.010 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.777963e-01 | 0.010 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.791213e-01 | 0.009 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.803674e-01 | 0.009 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.815391e-01 | 0.008 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.826410e-01 | 0.008 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.836772e-01 | 0.007 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.836772e-01 | 0.007 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.838503e-01 | 0.007 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.846516e-01 | 0.007 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.846516e-01 | 0.007 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.855679e-01 | 0.006 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.855679e-01 | 0.006 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.865996e-01 | 0.006 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.872397e-01 | 0.006 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.880017e-01 | 0.005 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.880017e-01 | 0.005 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.884663e-01 | 0.005 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.893918e-01 | 0.005 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.894517e-01 | 0.005 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.894517e-01 | 0.005 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.897554e-01 | 0.004 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.900253e-01 | 0.004 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.900253e-01 | 0.004 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.905240e-01 | 0.004 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.906211e-01 | 0.004 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.906211e-01 | 0.004 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.917080e-01 | 0.004 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.922033e-01 | 0.003 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.922033e-01 | 0.003 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.926691e-01 | 0.003 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.930339e-01 | 0.003 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.935835e-01 | 0.003 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.938334e-01 | 0.003 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.941505e-01 | 0.003 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.946126e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.949346e-01 | 0.002 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.953087e-01 | 0.002 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.957896e-01 | 0.002 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.964675e-01 | 0.002 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.970914e-01 | 0.001 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.970914e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.975619e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.977272e-01 | 0.001 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.979075e-01 | 0.001 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.979854e-01 | 0.001 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.983303e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.987736e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.988470e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.988810e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.990767e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.990992e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.992431e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.994153e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.994980e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.996071e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.996745e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.996848e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.997547e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.998077e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.998589e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.998611e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.998828e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999240e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999387e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999504e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999507e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999565e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999892e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999967e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999981e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999987e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999989e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999989e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999999e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |